https://curecurrent.com/trials/radiation-plus-cetuximab-in-locally-advanced-non-small-cell-lung-cancer-nsclc-54001https://curecurrent.com/trials/r115777-in-treating-patients-with-recurrent-or-metastatic-non-small-cell-lung-cancer-54002https://curecurrent.com/trials/radiotherapy-combined-with-iressa-for-egfr-mutation-positive-patients-with-locally-advanced-non-small-cell-lung-cancer-n-54003https://curecurrent.com/trials/genetic-epidemiological-study-of-lung-cancer-in-taiwan-and-clinical-applications-54004https://curecurrent.com/trials/red-morphine-drops-for-symptomatic-treatment-of-dyspnoea-in-lung-cancer-54005https://curecurrent.com/trials/a-study-to-assess-the-efficacy-of-erlotinib-for-leptomeningeal-carcinomatosis-in-egfr-mutation-positive-non-small-cell-l-54006https://curecurrent.com/trials/papilloma-virus-vaccine-therapy-in-treating-young-patients-with-recurrent-papilloma-of-the-larynx-54007https://curecurrent.com/trials/phase-1-2a-dose-ranging-study-of-tlk286-in-combination-with-docetaxel-in-platinum-resistant-non-small-cell-lung-cancer-54008https://curecurrent.com/trials/phase-2-study-of-tlk286-administered-weekly-in-advanced-non-small-cell-lung-cancer-54009https://curecurrent.com/trials/pemetrexed-cisplatin-versus-gemcitabine-cisplatin-according-to-thymidylate-synthase-expression-54010https://curecurrent.com/trials/tlk286-telcyta-in-combination-with-cisplatin-for-locally-advanced-or-metastatic-non-small-cell-lung-cancer-nsclc-54011https://curecurrent.com/trials/diagnostic-utility-of-pleural-fluid-mage-assay-in-patients-with-pleural-effusion-from-primary-lung-cancer-54012https://curecurrent.com/trials/paclitaxel-plus-carboplatin-with-or-without-endostar-in-patients-with-advanced-non-small-cell-lung-cancer-54013https://curecurrent.com/trials/the-depth-of-right-bronchial-blocker-placement-in-taiwanese-in-video-assisted-thoracoscopic-surgery-vats-54014https://curecurrent.com/trials/concurrent-and-non-concurrent-chemo-radiotherapy-or-radiotherapy-alone-for-patients-with-oligo-metastatic-stage-iv-non-s-54015https://curecurrent.com/trials/phase-i-cetuximab-and-concurrent-radio-chemotherapy-54016https://curecurrent.com/trials/study-comparing-ebus-eus-to-mediastinoscopy-in-staging-and-detection-of-lung-cancer-54017https://curecurrent.com/trials/curative-resectability-of-not-optimally-resectable-liver-and-or-lung-metastases-from-colorectal-carcinoma-crc-under-inte-54018https://curecurrent.com/trials/effects-of-radiation-therapy-on-the-body-in-patients-with-stage-iii-non-small-cell-lung-cancer-54019https://curecurrent.com/trials/a-study-of-nimotuzumab-in-combination-with-radiation-therapy-in-patients-with-brain-metastases-54020https://curecurrent.com/trials/a-study-of-nimotuzumab-in-combination-with-external-radiotherapy-in-non-small-cell-lung-cancer-54021https://curecurrent.com/trials/gv-1001-immunotherapy-in-patients-with-non-small-cell-lung-cancer-nsclc-54022https://curecurrent.com/trials/a-retrospective-egfr-mutation-status-study-in-chinese-nsclc-patients-using-paired-plasma-and-tissue-samples-54023https://curecurrent.com/trials/an-open-randomized-multicentre-phase-ii-pilot-study-54024https://curecurrent.com/trials/safety-study-of-cancer-specific-epitope-peptides-cocktail-for-cervical-gi-and-lung-tumors-54025https://curecurrent.com/trials/transbronchial-catheter-aspiration-and-transbronchial-needle-aspiration-in-the-diagnosis-of-lung-cancer-54026https://curecurrent.com/trials/celecoxib-in-preventing-lung-cancer-in-former-heavy-smokers-54027https://curecurrent.com/trials/gene-therapy-in-treating-patients-with-cancer-54028https://curecurrent.com/trials/study-of-salirasib-to-treat-non-small-cell-lung-cancer-54029https://curecurrent.com/trials/a-randomized-open-label-clinical-trial-of-the-pharmacokinetics-of-azithromycin-following-a-single-dose-of-azithromycin-s-54030https://curecurrent.com/trials/a-study-of-cetuximab-and-bevacizumab-in-combination-with-paclitaxel-and-carboplatin-in-stage-iiib-iv-nsclc-54031https://curecurrent.com/trials/safety-tolerance-and-efficacy-of-an-oral-nutritional-supplement-in-lung-cancer-patients-54032https://curecurrent.com/trials/phase-i-ii-study-of-azd2171-in-combination-with-paclitaxel-carboplatin-in-japanese-non-small-cell-lung-cancer-patients-54033https://curecurrent.com/trials/a-phase-ii-study-of-aczone-dapsone-gel-5-as-a-treatment-for-tarceva-erlotinib-related-rash-54034https://curecurrent.com/trials/the-roles-of-neutrophil-elastase-in-lung-cancer-54035https://curecurrent.com/trials/irinotecan-plus-cisplatin-vs-pemetrexed-plus-cisplatin-as-2nd-line-in-nsclc-stage-iiib-iv-54036https://curecurrent.com/trials/iressa-vs-placebo-as-maintenance-therapy-in-locally-advanced-nsclc-54037https://curecurrent.com/trials/trial-of-neoadjuvant-docetaxel-and-cisplatin-for-resectable-non-small-cell-lung-cancer-54038https://curecurrent.com/trials/cerebrospinal-fluid-levels-of-erlotinib-in-patients-receiving-erlotinib-for-stage-iii-non-small-cell-lung-cancer-54039https://curecurrent.com/trials/combination-chemotherapy-radiation-therapy-and-sargramostim-before-and-after-surgery-in-treating-patients-with-soft-tiss-54040https://curecurrent.com/trials/iressa-versus-docetaxel-taxotere-54041https://curecurrent.com/trials/isotretinoin-plus-interferon-in-treating-patients-with-recurrent-cancer-54042https://curecurrent.com/trials/iressa-in-poor-performance-status-patients-with-previously-untreated-advanced-non-small-cell-lung-cancer-54043https://curecurrent.com/trials/pemetrexed-in-patients-with-chemosensitive-and-chemoresistant-relapsed-small-cell-lung-cancer-54044https://curecurrent.com/trials/a-study-of-paclitaxel-plus-bevacizumab-in-patients-with-chemosensitive-relapsed-small-cell-lung-cancer-54045https://curecurrent.com/trials/a-study-of-bevacizumab-in-previously-untreated-extensive-stage-small-cell-lung-cancer-salute-54046https://curecurrent.com/trials/trimodality-therapy-for-malignant-pleural-mesothelioma-54047https://curecurrent.com/trials/pv701-in-treating-patients-with-advanced-or-recurrent-peritoneal-cancer-54048https://curecurrent.com/trials/phase-ii-study-of-weekly-paclitaxel-bms-181339-in-patient-with-non-small-cell-lung-cancer-nsclc-54049https://curecurrent.com/trials/hormone-changes-in-women-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-receiving-erlotinib-54050https://curecurrent.com/trials/maintenance-gemcitabine-in-the-chinese-advanced-lung-cancer-54051https://curecurrent.com/trials/bms-354825-in-patients-with-chronic-accelerated-or-blast-phase-chronic-myelogenous-leukemia-or-philadelphia-positive-acu-54052https://curecurrent.com/trials/chemotherapy-for-patients-with-non-small-cell-lung-cancer-nsclc-54053https://curecurrent.com/trials/a-study-to-find-the-best-dose-of-su011248-when-given-with-pemetrexed-pemetrexed-and-cisplatin-or-pemetrexed-and-carbopla-54054https://curecurrent.com/trials/safety-study-of-bevacizumab-avastin-with-thoracic-radiation-in-non-small-cell-cell-lung-cancer-54055https://curecurrent.com/trials/vinorelbine-gemcitabine-versus-vinorelbine-carboplatin-in-advanced-non-small-cell-lung-cancer-54056https://curecurrent.com/trials/survey-and-blood-sample-collection-for-patients-with-lung-cancer-who-never-smoked-cigarettes-54057https://curecurrent.com/trials/performance-status-during-treatment-with-pemetrexed-in-patients-with-nsclc-54058https://curecurrent.com/trials/valproic-acid-with-chemoradiotherapy-for-non-small-cell-lung-cancer-54059https://curecurrent.com/trials/computed-tomography-for-early-detection-of-cancer-in-women-who-are-at-risk-for-lung-cancer-54060https://curecurrent.com/trials/liposomal-cisplatin-analogue-l-nddp-in-treating-patients-with-malignant-pleural-mesothelioma-54061https://curecurrent.com/trials/phenethyl-isothiocyanate-in-preventing-lung-cancer-in-people-who-smoke-54062https://curecurrent.com/trials/development-and-application-of-rapid-nucleic-acid-diagnostic-kits-for-clinical-specimens-54063https://curecurrent.com/trials/study-of-bavituximab-plus-paclitaxel-and-carboplatin-in-patients-with-non-small-cell-lung-cancer-54064https://curecurrent.com/trials/epidemiological-study-to-evaluate-the-prevalence-of-epidermal-growth-factor-receptor-egfr-mutation-status-in-patients-wi-54065https://curecurrent.com/trials/iressa-for-egfr-mutation-negative-non-small-cell-lung-cancer-nsclc-54066https://curecurrent.com/trials/randomized-phase-iii-trial-of-surgery-alone-or-surgery-plus-preoperative-gemcitabine-cisplatin-in-clinical-early-stages-54067https://curecurrent.com/trials/genetic-changes-in-patients-with-non-small-cell-lung-cancer-who-are-receiving-vinorelbine-and-gemcitabine-before-surgery-54068https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-stage-i-stage-ii-or-stage-iiia-non-small-cell-lung-cancer-or-with-stage-i-or-s-54069https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-non-small-cell-lung-cancer-54070https://curecurrent.com/trials/photodynamic-therapy-with-hpph-in-treating-patients-with-non-small-cell-lung-cancer-54071https://curecurrent.com/trials/hyperthermia-thermal-therapy-with-chemotherapy-to-treat-inoperable-or-metastatic-tumors-54072https://curecurrent.com/trials/fludeoxyglucose-f18-positron-emission-tomography-imaging-in-assessing-patients-before-and-after-treatment-for-locally-ad-54073https://curecurrent.com/trials/surgery-and-photodynamic-therapy-in-treating-patients-with-malignant-mesothelioma-54074https://curecurrent.com/trials/investigation-of-safety-and-efficacy-of-sb-injection-in-patients-with-advanced-and-metastatic-non-small-cell-lung-cancer-54075https://curecurrent.com/trials/expanded-access-multicenter-study-of-lucanix-belagenpumatucel-l-54076https://curecurrent.com/trials/study-tests-the-safety-and-effectiveness-of-su011248-in-patients-with-non-small-cell-lung-cancer-having-brain-metastases-54077https://curecurrent.com/trials/a-study-of-pemetrexed-plus-carboplatin-combined-with-radiation-in-patients-with-inoperable-locally-advanced-non-small-ce-54078https://curecurrent.com/trials/first-line-combination-chemotherapy-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-that-can-54079https://curecurrent.com/trials/chemotherapy-with-or-without-radiosurgery-for-asymptomatic-oligo-brain-metastasis-54080https://curecurrent.com/trials/velcade-in-previously-treated-patients-with-stage-iiib-and-iv-bronchioloalveolar-carcinoma-bac-and-adenocarcinoma-with-b-54081https://curecurrent.com/trials/a-study-of-tarceva-for-use-in-patients-with-relapsed-or-refractory-metastatic-non-small-cell-lung-cancer-54082https://curecurrent.com/trials/evaluating-efficacy-and-safety-of-erlotinib-versus-gemcitabine-plus-cisplatin-as-neoadjuvant-chemotherapy-54083https://curecurrent.com/trials/vibration-response-imaging-vri-in-patients-who-are-potential-candidates-for-surgical-resection-54084https://curecurrent.com/trials/docetaxel-carboplatin-and-bevacizumab-in-treating-patients-with-stage-i-stage-ii-or-stage-iii-non-small-cell-lung-cancer-54085https://curecurrent.com/trials/study-of-cpap-as-intervention-after-lung-resection-54086https://curecurrent.com/trials/iressa-case-control-study-in-japan-54087https://curecurrent.com/trials/a-phase-i-study-of-zd1839-and-palliative-thoracic-radiotherapy-in-patients-with-non-small-cell-lung-cancer-54088https://curecurrent.com/trials/gemini-symbicort-pmdi-54089https://curecurrent.com/trials/the-correlation-between-lung-cancer-susceptibility-drug-response-and-genetic-polymorphism-54090https://curecurrent.com/trials/concomitant-tracheostomy-and-lung-resection-54091https://curecurrent.com/trials/trial-of-weekly-taxotere-and-irinotecan-cpt-11-in-patients-with-advanced-non-small-cell-lung-cancer-54092https://curecurrent.com/trials/respiratory-muscle-performance-and-functional-capacity-in-primary-stage-iiib-and-iv-lung-cancer-54093https://curecurrent.com/trials/a-phase-2-study-evaluating-abt-751-in-combination-with-taxotere-in-advanced-non-small-cell-lung-cancer-54094https://curecurrent.com/trials/study-of-adh-1-given-intravenously-to-patients-with-solid-tumors-54095https://curecurrent.com/trials/a-study-for-patients-with-non-squamous-non-small-cell-lung-cancer-54096https://curecurrent.com/trials/trial-of-erlotinib-with-or-without-pf-3512676-in-advanced-non-small-cell-lung-cancer-54097https://curecurrent.com/trials/pemetrexed-plus-gemcitabine-as-front-line-chemotherapy-for-patients-with-locally-advanced-or-metastatic-non-small-cell-l-54098https://curecurrent.com/trials/an-efficacy-and-safety-study-to-assess-18f-ml-10-in-detecting-response-of-tumors-to-chemotherapy-and-radiation-54099https://curecurrent.com/trials/assessment-of-surgical-staging-vs-endoscopic-ultrasound-in-lung-cancer-a-randomized-clinical-trial-aster-study-54100https://curecurrent.com/trials/study-of-the-fixation-of-various-vectors-in-pet-ct-in-patients-with-a-with-lung-cancer-before-and-during-of-crt-or-rt-54101https://curecurrent.com/trials/computed-tomography-ct-in-head-and-neck-patients-54102https://curecurrent.com/trials/lung-cancer-rehabilitation-study-54103https://curecurrent.com/trials/pemetrexed-carboplatin-vs-vinorelbine-carboplatin-in-patients-with-completely-resected-non-small-cell-lung-cancer-nsclc-54104https://curecurrent.com/trials/an-evaluation-of-the-clinical-treatment-and-patient-values-and-preferences-of-patients-suffering-from-advanced-non-small-54105https://curecurrent.com/trials/multicenter-phase-2-trial-evaluating-cisplatin-gemcitabine-with-concomitant-thoracic-radiotherapy-for-treatment-of-inope-54106https://curecurrent.com/trials/research-of-the-eml4-alk-gene-expression-in-the-pleural-effusion-or-tumor-tissue-from-lung-cancer-patients-54107https://curecurrent.com/trials/nis-observe-treatment-efficacy-in-maintaining-symptoms-control-in-moderate-severe-asthma-with-symbicort-smart-54108https://curecurrent.com/trials/methylated-genes-in-blood-as-biomarkers-for-advanced-lung-cancer-54109https://curecurrent.com/trials/evaluation-of-tolerability-of-adjuvant-cisplatin-docetaxel-in-completely-resected-stage-ib-ii-non-small-cell-lung-cancer-54110https://curecurrent.com/trials/expression-of-amp-activated-protein-kinase-ampk-protein-in-lung-adenocarcinoma-54111https://curecurrent.com/trials/expression-of-optic-atrophy-type-1-opa1-protein-in-lung-adenocarcinoma-54112https://curecurrent.com/trials/gemcitabine-in-long-infusion-and-cisplatin-for-malignant-pleural-mesothelioma-treatment-54113https://curecurrent.com/trials/gleevec-maintenance-therapy-after-induction-irinotecan-and-cisplatin-in-patients-with-c-kit-positive-extensive-sclc-54114https://curecurrent.com/trials/dendritic-cell-based-immunotherapy-in-mesothelioma-54115https://curecurrent.com/trials/chemotherapy-for-patients-with-non-small-cell-lung-cancer-54116https://curecurrent.com/trials/association-between-vegf-c-and-mirna-and-clinical-non-small-cell-lung-cancer-and-esophagus-squamous-cell-carcinoma-54117https://curecurrent.com/trials/respiration-gated-laser-guided-ct-lung-nodule-biopsy-54118https://curecurrent.com/trials/pharmacogenomic-study-realized-on-non-small-cell-lung-carcinoma-54119https://curecurrent.com/trials/first-line-gefitinib-versus-chemotherapy-for-lung-adenocarcinoma-in-never-smoker-54120https://curecurrent.com/trials/a-study-of-ts-1-plus-irinotecan-and-cisplatin-ip-for-patients-with-stage-iiib-iv-non-small-cell-lung-cancer-nsclc-54121https://curecurrent.com/trials/gemcitabine-plus-oxaliplatin-in-advanced-stage-iiib-iv-non-small-cell-lung-cancer-nsclc-54122https://curecurrent.com/trials/adjuvant-gemcitabine-plus-oxaliplatin-versus-gemcitabine-plus-cisplatin-for-completely-resected-stage-ib-ii-iiia-nsclc-54123https://curecurrent.com/trials/the-use-of-a-quality-of-life-questionnaire-in-patients-with-lung-cancer-54124https://curecurrent.com/trials/lbh-phase-ii-in-small-cell-lung-cancer-sclc-54125https://curecurrent.com/trials/ebus-guided-cryo-biopsy-of-solitary-pulmonary-nodules-54126https://curecurrent.com/trials/abx-egf-as-second-line-treatment-of-advanced-non-small-cell-lung-cancer-nsclc-54127https://curecurrent.com/trials/pemetrexed-carboplatin-non-small-cell-lung-cancer-nsclc-elderly-patients-54128https://curecurrent.com/trials/management-of-advanced-non-small-cell-lung-cancer-nsclc-and-clinical-outcomes-in-patients-who-received-gefitinib-in-thai-54129https://curecurrent.com/trials/phase-ii-trial-of-sunitinib-in-bac-or-never-smokers-with-any-lung-adenocarcinoma-54130https://curecurrent.com/trials/ispinesib-in-patients-with-advanced-or-metastatic-non-small-cell-lung-cancer-54131https://curecurrent.com/trials/inter-costal-catheters-for-video-assisted-thoroscopic-vats-lobectomy-54132https://curecurrent.com/trials/study-of-concurrent-chemo-radiotherapy-combined-with-recombinant-human-endostatin-for-local-advanced-non-small-cell-lung-54133https://curecurrent.com/trials/endoplasmic-reticulum-stress-in-chronic-respiratory-diseases-54134https://curecurrent.com/trials/sunitinib-as-maintenance-therapy-in-treating-patients-with-stage-iii-or-stage-iv-non-small-cell-lung-cancer-54135https://curecurrent.com/trials/study-of-paclitaxel-carboplatin-and-cetuximab-for-advanced-lung-cancer-54136https://curecurrent.com/trials/impact-of-endostar-combined-with-chemotherapy-on-the-angiogenesis-of-advanced-non-small-cell-lung-cancer-nsclc-54137https://curecurrent.com/trials/study-of-endostatin-combined-with-docetaxel-in-the-treatment-of-advanced-non-small-cell-lung-cancer-patients-54138https://curecurrent.com/trials/docetaxel-in-non-small-cell-lung-cancer-nsclc-54139https://curecurrent.com/trials/study-to-investigate-bronchial-arterrial-infusing-bai-plus-three-dimensional-conformal-radiotherapy-3dcrt-in-local-advan-54140https://curecurrent.com/trials/bronchoscopic-approach-to-the-peripheral-lung-nodule-an-alternative-approach-54141https://curecurrent.com/trials/chemotherapy-for-patients-with-non-small-cell-lung-cancer-who-are-non-smokers-54142https://curecurrent.com/trials/study-of-gefitinib-compared-with-pemetrexed-cisplatin-in-advanced-non-small-cell-lung-cancer-patients-54143https://curecurrent.com/trials/initial-assessment-of-the-effect-of-the-addition-of-disulfiram-antabuse-to-standard-chemotherapy-in-lung-cancer-54144https://curecurrent.com/trials/efficacy-study-of-induction-chemotherapy-before-surgery-in-operable-non-small-cell-lung-cancer-54145https://curecurrent.com/trials/a-randomized-phase-2-study-of-at-101-in-combination-with-docetaxel-in-relapsed-refractory-non-small-cell-lung-cancer-54146https://curecurrent.com/trials/colon-cancer-prognosis-after-radical-surgery-54147https://curecurrent.com/trials/study-of-at-101-in-combination-with-topotecan-in-relapsed-refractory-small-cell-lung-cancer-54148https://curecurrent.com/trials/preoperative-chemoradiotherapy-versus-chemotherapy-alone-in-nonsmall-cell-lung-cancer-nsclc-patients-with-mediastinal-ly-54149https://curecurrent.com/trials/trial-of-pemetrexed-versus-erlotinib-in-pretreated-patients-with-non-small-cell-lung-cancer-nsclc-54150https://curecurrent.com/trials/chemotherapy-treatment-in-re-occurring-non-small-cell-lung-cancer-nsclc-after-previous-chemotherapy-and-surgical-removal-54151https://curecurrent.com/trials/gemcitabine-and-carboplatin-followed-by-docetaxel-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-c-54152https://curecurrent.com/trials/epidemiological-study-to-describe-nsclc-clinical-management-patterns-in-europe-lung-epiclin-54153https://curecurrent.com/trials/fragmin-in-the-treatment-of-acute-deep-vein-thrombosis-with-or-without-pulmonary-embolism-in-cancer-patients-54154https://curecurrent.com/trials/the-role-of-narrow-band-imaging-videobronchoscopy-in-lung-cancer-54155https://curecurrent.com/trials/broccoli-sprout-extract-in-preventing-lung-cancer-in-smokers-54156https://curecurrent.com/trials/gemcitabine-and-carboplatin-followed-by-paclitaxel-in-treating-patients-with-stage-iii-or-stage-iv-non-small-cell-lung-c-54157https://curecurrent.com/trials/laboratory-test-in-predicting-response-to-erlotinib-in-patients-with-relapsed-metastatic-or-unresectable-non-small-cell-54158https://curecurrent.com/trials/ucn-01-and-irinotecan-in-treating-patients-with-advanced-solid-tumors-54159https://curecurrent.com/trials/safety-and-tolerability-profile-of-rad001-daily-in-chinese-patients-with-advanced-pulmonary-neuroendocrine-tumor-54160https://curecurrent.com/trials/tyrosine-kinase-inhibitors-in-metastatic-non-small-cell-lung-cancer-54161https://curecurrent.com/trials/phase-ii-study-of-lucanix-in-patients-with-stages-ii-iv-non-small-cell-lung-cancer-54162https://curecurrent.com/trials/weekly-topotecan-in-the-second-line-treatment-of-small-cell-lung-cancer-54163https://curecurrent.com/trials/study-of-paclitaxel-carboplatin-and-gemcitabine-versus-gemcitabine-and-vinorelbine-for-non-small-cell-lung-cancer-54164https://curecurrent.com/trials/fdg-pet-scan-response-guided-chemotherapy-strategy-for-advanced-non-small-cell-lung-cancer-54165https://curecurrent.com/trials/weekly-topotecan-in-the-first-line-treatment-of-elderly-patients-with-small-cell-lung-cancer-54166https://curecurrent.com/trials/effect-of-neutrophil-elastase-inhibitor-on-lung-injury-after-esophagectomy-54167https://curecurrent.com/trials/weekly-docetaxel-and-four-weekly-carboplatin-in-non-small-cell-lung-cancer-carbo-tax-54168https://curecurrent.com/trials/concurrent-chemo-radiation-form-nsclc-to-a-individualized-mld-54169https://curecurrent.com/trials/radiotherapy-for-nsclc-to-a-individualized-mld-54170https://curecurrent.com/trials/lenalidomide-and-cetuximab-in-patients-with-advanced-solid-tumors-54171https://curecurrent.com/trials/dna-repair-genes-and-outcomes-in-patients-with-stage-iii-nsclc-54172https://curecurrent.com/trials/an-investigation-of-tumor-necrosis-factor-tnf-alpha-in-asthma-using-biopsy-explants-and-primary-bronchial-epithelial-cel-54173https://curecurrent.com/trials/pre-operative-chemotherapy-versus-concurrent-chemoradiotherapy-in-n2-positive-iiia-non-small-cell-lung-cancer-nsclc-54174https://curecurrent.com/trials/weekly-paclitaxel-plus-gemcitabine-as-second-line-in-small-cell-lung-cancer-54175https://curecurrent.com/trials/study-of-pemetrexed-in-mesothelioma-and-lung-cancer-patients-with-fluid-around-the-lungs-or-abdomen-54176https://curecurrent.com/trials/prophylactic-cranial-irradiation-in-erlotinib-gefitinib-responders-with-non-small-cell-lung-cancer-nsclc-rt1001-54177https://curecurrent.com/trials/concurrent-endostar-paclitaxel-carboplatin-and-radiotherapy-for-locally-advanced-non-small-cell-lung-rt0902-54178https://curecurrent.com/trials/study-of-efficacy-of-induction-chemotherapy-with-gemcitabine-and-carboplatin-for-operable-non-small-cell-lung-cancer-bef-54179https://curecurrent.com/trials/gene-therapy-plus-radiation-therapy-in-treating-patients-with-non-small-cell-lung-cancer-54180https://curecurrent.com/trials/defining-the-utility-of-pet-ct-in-the-follow-up-of-patients-with-solid-tumors-54181https://curecurrent.com/trials/bortezomib-and-topotecan-in-treating-patients-with-advanced-solid-tumors-54182https://curecurrent.com/trials/first-line-treatment-for-adenocarcinoma-patients-with-epidermal-growth-factor-receptor-egfr-mutation-54183https://curecurrent.com/trials/the-character-of-perfusion-parameters-derived-from-mdct-between-adenocarcinoma-and-squamous-cell-carcinoma-of-lung-in-th-54184https://curecurrent.com/trials/irinotecan-carboplatin-bevacizumab-in-the-treatment-of-patients-with-extensive-stage-small-cell-lung-cancer-54185https://curecurrent.com/trials/oral-topotecan-versus-docetaxel-in-second-line-treatment-of-non-small-cell-lung-cancer-54186https://curecurrent.com/trials/gleevec-combined-with-camptosar-plus-paraplatin-in-previously-untreated-extensive-stage-small-cell-lung-cancer-54187https://curecurrent.com/trials/weekly-docetaxel-versus-weekly-docetaxel-gemcitabine-in-the-treatment-of-non-small-cell-lung-cancer-in-elderly-patients-54188https://curecurrent.com/trials/trial-of-a-breathlessness-intervention-service-for-intractable-breathlessness-54189https://curecurrent.com/trials/transbronchial-needle-aspiration-in-the-diagnosis-of-peripheral-pulmonary-malignancy-54190https://curecurrent.com/trials/irinotecan-carboplatin-bevacizumab-and-radiation-therapy-in-the-treatment-of-limited-stage-small-cell-lung-cancer-54191https://curecurrent.com/trials/transbronchial-needle-forceps-for-endobronchial-ultrasound-54192https://curecurrent.com/trials/docetaxel-intermittent-erlotinib-tarceva-in-metastatic-non-small-cell-lung-cancer-nsclc-54193https://curecurrent.com/trials/two-rebeccamycin-analogue-regimens-in-treating-patients-with-advanced-or-recurrent-non-small-cell-lung-cancer-54194https://curecurrent.com/trials/non-small-cell-lung-cancer-evaluation-according-to-pre-determined-drug-targeting-tumor-markers-54195https://curecurrent.com/trials/a-retrospective-pharmacoeconomic-study-of-lung-cancer-54196https://curecurrent.com/trials/thalidomide-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-54197https://curecurrent.com/trials/chemotherapy-in-treating-patients-with-advanced-non-small-cell-lung-cancer-54198https://curecurrent.com/trials/a-chinese-randomized-crossover-study-of-erlotinib-versus-docetaxel-cisplatin-in-previously-untreated-stage-iiib-iv-lung-54199https://curecurrent.com/trials/the-continuation-of-erlotinib-54200https://curecurrent.com/trials/asymptomatic-brain-metastasis-in-non-small-cell-lung-cancer-nsclc-54201https://curecurrent.com/trials/a-study-on-the-long-term-survivals-in-an-expand-access-program-eap-of-iressa-54202https://curecurrent.com/trials/study-of-aerosolized-liposomal-9-nitro-20-s-camptothecin-l9nc-54203https://curecurrent.com/trials/a-study-of-su011248-as-therapy-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-54204https://curecurrent.com/trials/erlotinib-combined-with-radiotherapy-in-patients-with-non-resectable-locally-advanced-non-small-cell-lung-cancer-la-nscl-54205https://curecurrent.com/trials/adjuvant-vinorelbine-plus-cisplatin-np-versus-np-plus-endostar-in-patients-with-completely-resected-stage-ib-iiia-non-sm-54206https://curecurrent.com/trials/effectiveness-of-a-hand-held-fan-for-breathlessness-54207https://curecurrent.com/trials/epidemiologic-study-of-kras-mutation-in-brazilian-patients-with-advanced-or-metastatic-non-small-cell-lung-cancer-54208https://curecurrent.com/trials/a-study-of-bevacizumab-plus-carboplatin-and-paclitaxel-in-subjects-with-advanced-previously-untreated-squamous-non-small-54209https://curecurrent.com/trials/randomized-phase-2-study-of-3-therapeutic-modalities-in-ps-2-3-patients-with-nsclc-stage-iiib-iv-54210https://curecurrent.com/trials/canbesure-study-cancer-bemiparin-and-surgery-evaluation-54211https://curecurrent.com/trials/identification-of-serum-markers-for-tumor-hypoxia-in-non-small-cell-lung-cancers-54212https://curecurrent.com/trials/factor-xiii-and-pulmonary-embolism-in-neurosurgical-patients-54213https://curecurrent.com/trials/radiofrequency-ablation-combined-with-chemotherapy-for-pulmonary-tumors-54214https://curecurrent.com/trials/pain-outcomes-following-video-assisted-thoracic-surgery-vats-with-lap-protector-54215https://curecurrent.com/trials/phase-ii-study-in-patients-with-recurrent-non-small-cell-lung-cancer-54216https://curecurrent.com/trials/carboplatin-plus-cetuximab-for-treatment-of-stage-iiib-iv-non-small-cell-lung-cancer-nsclc-54217https://curecurrent.com/trials/study-of-cetuximab-in-combination-with-carboplatin-paclitaxel-in-non-small-cell-lung-cancer-54218https://curecurrent.com/trials/trial-of-carboplatin-paclitaxel-cetuximab-in-stage-iiib-iv-non-small-cell-lung-cancer-nsclc-54219https://curecurrent.com/trials/survival-in-a-randomized-phase-iii-trial-in-patients-with-limited-disease-ld-small-cell-lung-cancer-vaccinated-with-adju-54220https://curecurrent.com/trials/pemetrexed-disodium-and-erlotinib-in-treating-patients-with-advanced-non-small-cell-lung-cancer-or-other-solid-tumors-54221https://curecurrent.com/trials/an-open-label-study-of-a-peptide-vaccine-in-patients-with-stage-iib-or-iiia-non-small-cell-lung-cancer-54222https://curecurrent.com/trials/clinical-application-of-18f-3-fluoro-3-deoxy-l-thymidine-18f-flt-positron-emission-tomography-pet-in-lung-tumors-54223https://curecurrent.com/trials/phase-1-study-of-tg01-and-erlotinib-in-non-small-cell-lung-cancer-ncslc-patients-54224https://curecurrent.com/trials/an-exploratory-open-label-multi-center-non-randomized-study-of-f-18-vm4-037-54225https://curecurrent.com/trials/a-radiolabeled-mass-balance-study-of-14c-pf-00299804-in-healthy-male-volunteers-54226https://curecurrent.com/trials/adjuvant-vinorelbine-plus-cisplatin-np-versus-np-plus-endostar-in-patients-with-completely-resected-stage-ib-iiia-non-sm-54227https://curecurrent.com/trials/second-line-treatment-in-patients-with-small-cell-lung-cancer-sclc-54228https://curecurrent.com/trials/sorafenib-in-bac-or-never-smokers-with-lung-adenocarcinoma-54229https://curecurrent.com/trials/oral-taxane-in-combination-with-pemetrexed-alimta-in-patients-with-recurrent-non-small-cell-lung-cancer-54230https://curecurrent.com/trials/study-of-bms-275183-in-patients-with-pretreated-locally-advanced-or-metastatic-nsclc-non-small-cell-lung-cancer-54231https://curecurrent.com/trials/study-of-bms-275183-in-patients-with-pre-treated-non-small-cell-lung-cancer-54232https://curecurrent.com/trials/safety-study-of-seneca-valley-virus-in-patients-with-solid-tumors-with-neuroendocrine-features-54233https://curecurrent.com/trials/stereotactic-radiosurgery-in-treating-patients-with-liver-metastases-lung-metastases-or-other-advanced-solid-tumors-54234https://curecurrent.com/trials/study-of-xl999-in-patients-with-non-small-cell-lung-cancer-54235https://curecurrent.com/trials/safety-study-of-xl999-in-adults-with-non-small-cell-lung-cancer-54236https://curecurrent.com/trials/rapid-on-site-cytopathologic-evaluation-in-the-diagnosis-of-hilar-mediastinal-adenopathy-54237https://curecurrent.com/trials/study-of-irinotecan-hydrochloride-campto-r-and-cisplatin-versus-etoposide-and-cisplatin-in-small-cell-lung-cancer-54238https://curecurrent.com/trials/pulmonart-docetaxel-non-small-cell-lung-cancer-nsclc-54239https://curecurrent.com/trials/chemotherapy-with-pemetrexed-in-combination-with-platinum-for-advanced-non-small-cell-lung-cancer-nsclc-54240https://curecurrent.com/trials/gemcitabine-or-gemcitabine-plus-docetaxel-after-cisplatin-etoposide-and-radiation-in-non-small-cell-lung-cancer-nsclc-54241https://curecurrent.com/trials/evaluation-of-the-lungpoint-virtual-bronchoscopic-navigation-vbn-system-54242https://curecurrent.com/trials/neoadjuvant-chemoradiotherapy-followed-by-surgery-in-treating-patients-with-limited-stage-small-cell-lung-cancer-54243https://curecurrent.com/trials/radiofrequency-ablation-during-surgery-in-treating-patients-with-non-small-cell-lung-cancer-54244https://curecurrent.com/trials/pemetrexed-alimta-and-gefitinib-iressa-in-never-smoker-and-adenocarcinoma-patients-with-non-small-cell-lung-cancer-previ-54245https://curecurrent.com/trials/study-using-induction-chemotherapy-and-intensity-modulated-radiation-therapy-guided-by-combined-ct-and-pet-imaging-for-p-54246https://curecurrent.com/trials/fentanyl-matrix-in-lung-cancer-pain-54247https://curecurrent.com/trials/study-to-assess-safety-and-tolerability-of-azd0530-in-combination-with-carboplatin-and-paclitaxel-54248https://curecurrent.com/trials/effectiveness-of-kos-862-in-the-treatment-of-lung-cancer-54249https://curecurrent.com/trials/pre-operative-chemotherapy-versus-concurrent-chemoradiotherapy-in-locally-advanced-non-small-cell-lung-cancer-54250https://curecurrent.com/trials/inositol-in-preventing-lung-cancer-in-patients-with-bronchial-epithelial-dysplasia-who-are-current-or-former-smokers-54251https://curecurrent.com/trials/video-assisted-thoracoscopic-surgery-for-stage-iiia-non-small-cell-lung-cancer-54252https://curecurrent.com/trials/docetaxel-and-thalidomide-as-second-line-therapy-in-treating-patients-with-stage-iii-or-stage-iv-non-small-cell-lung-can-54253https://curecurrent.com/trials/established-lung-cancer-cell-line-and-stroma-cell-from-surgical-tissue-54254https://curecurrent.com/trials/study-in-patients-with-advanced-non-small-cell-lung-cancer-treated-with-pemetrexed-and-carboplatin-plus-or-minus-sorafen-54255https://curecurrent.com/trials/multicenter-evaluation-of-docetaxel-gemcitabine-and-bevacizumab-combination-followed-by-bevacizumab-alone-in-subjects-wi-54256https://curecurrent.com/trials/second-line-therapy-study-of-combined-chemotherapy-and-endostar-to-patients-with-non-small-cell-lung-cancer-nsclc-54257https://curecurrent.com/trials/esophagectomy-associated-respiratory-complications-ivor-lewis-versus-sweet-approaches-54258https://curecurrent.com/trials/docetaxel-irinotecan-and-carboplatin-in-extensive-stage-non-small-cell-lung-cancer-54259https://curecurrent.com/trials/therapeutic-and-prognostic-impact-of-circulating-tumor-cells-in-peripheral-blood-in-patients-with-non-small-cell-lung-ca-54260https://curecurrent.com/trials/pegylated-liposomal-doxorubicin-and-carboplatin-as-first-line-treatment-for-patients-with-advanced-non-small-cell-lung-c-54261https://curecurrent.com/trials/bortezomib-velcade-pemetrexed-alimta-in-advanced-nsclc-54262https://curecurrent.com/trials/effect-on-the-nutritional-and-inflammatory-status-of-docosahexaenoic-acid-dha-and-eicosapentaenoic-acid-epa-containing-s-54263https://curecurrent.com/trials/effect-of-all-trans-retinoic-acid-with-chemotherapy-based-in-paclitaxel-and-cisplatin-as-first-line-treatment-of-patient-54264https://curecurrent.com/trials/aerosolized-liposomal-camptothecin-in-patients-with-metastatic-or-recurrent-cancer-of-the-endometrium-or-the-lung-54265https://curecurrent.com/trials/concurrent-radiotherapy-with-weekly-topotecan-for-primary-treatment-of-inoperable-localized-non-small-cell-lung-cancer-54266https://curecurrent.com/trials/assisted-vats-sleeve-lobectomy-for-non-small-cell-lung-cancer-54267https://curecurrent.com/trials/effect-of-all-trans-retinoic-acid-with-chemotherapy-based-on-paclitaxel-and-cisplatin-as-first-line-treatment-of-patient-54268https://curecurrent.com/trials/safety-and-tolerability-study-of-apn01-recombinant-human-angiotensin-converting-enzyme-2-54269https://curecurrent.com/trials/safety-study-of-docetaxel-cisplatin-induction-therapy-followed-by-concurrent-chemoradiotherapy-or-concurrent-chemoradiot-54270https://curecurrent.com/trials/ufur-tegafur-uracil-plus-iressa-in-non-small-cell-lung-cancer-54271https://curecurrent.com/trials/erlotinib-as-1st-line-treatment-in-nsclc-stage-iiib-iv-54272https://curecurrent.com/trials/docetaxel-pemetrexed-as-1st-line-treatment-in-patients-with-non-small-cell-lung-cancer-nsclc-54273https://curecurrent.com/trials/mesothelin-and-osteopontin-as-diagnostic-markers-in-patients-with-mesothelioma-or-atypical-mesothelial-hyperplasia-54274https://curecurrent.com/trials/to-investigate-efficacy-and-safety-of-pemetrexed-as-second-or-third-line-therapy-in-patients-with-non-small-cell-lung-ca-54275https://curecurrent.com/trials/a-study-of-endostar-combined-with-chemotherapy-followed-by-endostar-maintenance-therapy-to-treat-advanced-non-small-cell-54276https://curecurrent.com/trials/docetaxel-in-non-small-cell-lung-cancer-nsclc-54277https://curecurrent.com/trials/advanced-phase-ii-trial-of-weekly-vs-3-weekly-docetaxel-and-cisplatin-followed-by-gemcitabine-in-non-small-cell-lung-can-54278https://curecurrent.com/trials/taxotere-combinations-as-first-line-therapy-for-locally-advanced-unresectable-or-metastatic-non-small-cell-lung-cancer-54279https://curecurrent.com/trials/efficacy-study-of-gemox-combination-and-vinorelbine-in-nscl-patients-54280https://curecurrent.com/trials/gilt-docetaxel-non-small-cell-lung-cancer-54281https://curecurrent.com/trials/the-use-of-breathing-synchronized-pet-ct-imaging-in-the-detection-and-quantification-of-fdg-uptake-in-lung-nodules-54282https://curecurrent.com/trials/detection-of-egfr-mutation-in-malignant-pleural-effusion-of-lung-cancer-patients-and-cancer-cell-lines-establishment-54283https://curecurrent.com/trials/salvage-therapy-with-sunitinib-docetaxel-and-platinum-on-metastatic-or-unresectable-non-small-cell-lung-cancer-54284https://curecurrent.com/trials/non-small-cell-lung-cancer-registry-54285https://curecurrent.com/trials/chemotherapy-and-radiotherapy-to-treat-patients-with-limited-stage-of-small-cell-lung-cancer-sclc-54286https://curecurrent.com/trials/phase-i-ii-study-of-genasense-in-patients-with-chronic-lymphocytic-leukemia-54287https://curecurrent.com/trials/low-dose-weekly-docetaxel-versus-pemetrexed-in-previously-treated-advanced-non-small-cell-lung-cancer-54288https://curecurrent.com/trials/a-study-to-treat-small-cell-lung-cancer-with-a-combination-of-cisplatin-pemetrexed-and-radiotherapy-54289https://curecurrent.com/trials/study-of-pemetrexed-and-carboplatin-compared-with-etoposide-carboplatin-to-treat-extensive-stage-small-cell-lung-cancer-54290https://curecurrent.com/trials/evaluation-of-stents-to-open-restricted-airways-in-patients-with-centrally-placed-non-small-cell-lung-cancer-54291https://curecurrent.com/trials/the-role-of-positron-emission-tomography-pet-during-erlotinib-treatment-for-non-small-cell-lung-cancer-54292https://curecurrent.com/trials/dosage-schedule-study-of-pemetrexed-monochemotherapy-for-locally-advanced-or-metastatic-non-small-cell-lung-cancer-nsclc-54293https://curecurrent.com/trials/phase-i-ii-trial-of-infusional-gemcitabine-in-combination-with-carboplatin-in-chemonaive-non-small-cell-carcinoma-54294https://curecurrent.com/trials/ebus-guided-tbna-for-molecular-diagnostic-of-mediastinal-lymph-nodes-ln-54295https://curecurrent.com/trials/study-comparing-amrubicin-versus-topotecan-in-patients-with-small-cell-lung-cancer-who-have-responded-to-prior-therapy-54296https://curecurrent.com/trials/trial-of-pemetrexed-with-or-without-pf-3512676-in-advanced-non-small-cell-lung-cancer-54297https://curecurrent.com/trials/randomized-ph-2-trial-of-paclitaxel-carboplatin-bevacizumab-pf-3512676-and-p-c-b-alone-in-advanced-nonsquamous-nsclc-54298https://curecurrent.com/trials/prophylaxis-of-fungal-invasive-infections-in-leukemia-54299https://curecurrent.com/trials/neoadjuvant-chemotherapy-in-non-small-cell-lung-cancer-nsclc-stages-ib-iia-iib-and-iiia-t3-54300https://curecurrent.com/trials/study-of-carboplatin-and-vinorelbine-in-malignant-pleural-mesothelioma-54301https://curecurrent.com/trials/erlotinib-and-sequential-positron-emission-tomography-pet-in-advanced-non-small-cell-lung-cancer-nsclc-54302https://curecurrent.com/trials/a-study-of-bms-663513-in-combination-with-chemoradiation-in-subjects-with-non-small-cell-lung-carcinoma-nsclc-54303https://curecurrent.com/trials/oral-nrx-194204-study-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-54304https://curecurrent.com/trials/sorafenib-and-erlotinib-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-that-has-not-respond-54305https://curecurrent.com/trials/paclitaxel-and-irinotecan-in-treating-patients-with-advanced-non-small-cell-lung-cancer-54306https://curecurrent.com/trials/hot-and-cold-biopsy-forceps-in-the-diagnosis-of-endobronchial-lesions-54307https://curecurrent.com/trials/study-evaluating-ekb-569-in-advanced-non-small-cell-lung-cancer-54308https://curecurrent.com/trials/study-evaluating-mac-321-in-non-small-cell-lung-cancer-refractory-to-platinum-based-therapy-54309https://curecurrent.com/trials/a-study-of-sunitinib-in-combination-with-bevacizumab-carboplatin-and-paclitaxel-in-patients-with-advanced-non-small-cell-54310https://curecurrent.com/trials/endobronchial-valve-for-emphysema-palliation-trial-vent-54311https://curecurrent.com/trials/study-evaluating-etanercept-in-moderate-to-severe-asthma-54312https://curecurrent.com/trials/combination-chemotherapy-and-monoclonal-antibody-therapy-in-treating-patients-with-advanced-colorectal-cancer-with-liver-54313https://curecurrent.com/trials/pemetrexed-carboplatin-as-second-line-treatment-in-nsclc-54314https://curecurrent.com/trials/phase-ii-iressa-carbo-gem-in-nsclc-54315https://curecurrent.com/trials/a-phase-1-2-xiap-antisense-aeg35156-with-carboplatin-and-paclitaxel-in-patients-with-advanced-non-small-cell-lung-cancer-54316https://curecurrent.com/trials/pemetrexed-plus-cisplatin-for-brain-metastasis-of-advanced-non-small-cell-lung-cancer-nsclc-54317https://curecurrent.com/trials/sorafenib-in-resected-non-small-cell-lung-carcinoma-54318https://curecurrent.com/trials/oral-vinorelbine-and-cisplatin-and-concurrent-radiotherapy-after-induction-chemotherapy-in-locally-advanced-nsclc-54319https://curecurrent.com/trials/cetuximab-and-vinorelbine-in-elderly-subjects-with-lung-cancer-54320https://curecurrent.com/trials/combination-chemotherapy-with-or-without-surgery-and-radiation-therapy-in-treating-patients-with-mesothelioma-that-can-b-54321https://curecurrent.com/trials/epidemiology-of-venous-thromboembolism-54322https://curecurrent.com/trials/hypofractionated-intensity-modulated-chemoradiotherapy-to-treat-locally-advanced-non-small-cell-lung-cancer-54323https://curecurrent.com/trials/incidence-of-postthoracotomy-pain-following-general-anesthesia-a-comparison-between-tiva-and-inhalation-anesthesia-54324https://curecurrent.com/trials/high-tidal-volume-induces-inflammation-in-normal-lungs-54325https://curecurrent.com/trials/iressa-in-the-treatment-of-brain-metastases-from-non-small-cell-lung-cancer-54326https://curecurrent.com/trials/safety-study-of-individualised-radiation-dose-determination-for-lung-cancer-patients-54327https://curecurrent.com/trials/phase-ii-study-of-celecoxib-and-concurrent-radiotherapy-in-stage-ii-iii-nsclc-54328https://curecurrent.com/trials/effect-of-celecoxib-on-survival-in-patients-with-advanced-non-small-cell-lung-cancer-receiving-chemotherapy-54329https://curecurrent.com/trials/hi-chart-feasibility-of-high-dose-accelerated-conformal-radiotherapy-54330https://curecurrent.com/trials/predictive-value-of-fdg-pet-ct-scans-for-patients-with-lung-cancer-receiving-concurrent-chemo-radiation-54331https://curecurrent.com/trials/mediastinal-staging-of-lung-cancer-with-ebus-tbna-and-eus-b-fna-54332https://curecurrent.com/trials/evaluation-of-bay-59-8862-in-taxane-resistant-non-small-cell-lung-cancer-patients-54333https://curecurrent.com/trials/pemetrexed-plus-oxaliplatin-as-adjuvant-chemotherapy-for-radically-resected-non-small-cell-lung-cancer-54334https://curecurrent.com/trials/diagnosis-of-lung-lesions-by-endobronchial-ultrasound-with-an-alternative-guide-sheath-54335https://curecurrent.com/trials/concurrent-chemo-radiotherapy-for-limited-disease-small-cell-lung-cancer-ld-sclc-on-basis-of-fdg-pet-scans-54336https://curecurrent.com/trials/vibration-response-imaging-vri-in-patients-that-are-candidates-for-undergoing-pulmonary-operation-procedure-54337https://curecurrent.com/trials/the-incidence-of-trali-in-patients-undergoing-orthopedic-oncology-surgery-54338https://curecurrent.com/trials/safety-and-efficacy-of-s-8184-in-second-line-treatment-of-relapsed-stage-iiib-or-iv-non-small-cell-lung-cancer-54339https://curecurrent.com/trials/pemetrexed-and-gemcitabine-every-14-days-versus-every-21-days-in-advanced-non-small-cell-lung-cancer-54340https://curecurrent.com/trials/pemetrexed-and-cisplatin-treatment-before-surgery-in-non-small-cell-lung-cancer-54341https://curecurrent.com/trials/pemetrexed-and-cisplatin-as-treatment-in-small-cell-lung-cancer-54342https://curecurrent.com/trials/erlotinib-and-docetaxel-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-nsclc-after-failure-o-54343https://curecurrent.com/trials/biweekly-gemcitabine-and-docetaxel-as-first-line-therapy-for-advanced-non-small-cell-lung-cancer-nsclc-patients-54344https://curecurrent.com/trials/biweekly-gemcitabine-and-docetaxel-as-first-line-treatment-for-advanced-disease-in-elderly-non-small-cell-lung-cancer-ns-54345https://curecurrent.com/trials/pharmacoeconomic-assessment-iressa-in-the-treatment-of-non-small-cell-lung-cancer-nsclc-54346https://curecurrent.com/trials/trial-of-chemotherapy-followed-by-pulsed-docetaxel-and-concurrent-radiation-for-non-small-cell-lung-cancer-54347https://curecurrent.com/trials/tailored-second-line-treatment-by-epidermal-growth-factor-receptor-egfr-mutation-in-patients-with-advanced-lung-adenocar-54348https://curecurrent.com/trials/nebulized-liposomal-amphotericin-b-ambisome-for-prophylaxis-of-invasive-pulmonary-aspergillosis-54349https://curecurrent.com/trials/safety-and-efficacy-study-of-glufosfamide-in-patients-with-recurrent-sensitive-small-cell-lung-carcinoma-54350https://curecurrent.com/trials/phase-ii-iressa-versus-vinorelbine-invite-54351https://curecurrent.com/trials/suberoylanilide-hydroxamic-acid-in-advanced-solid-tumors-54352https://curecurrent.com/trials/palliative-treatment-with-liposomal-doxorubicin-plus-cisplatin-for-patients-with-malignant-pleural-mesothelioma-54353https://curecurrent.com/trials/concurrent-chemotherapy-and-radiotherapy-with-nitroglycerin-in-patients-with-locally-advanced-non-small-cell-lung-cancer-54354https://curecurrent.com/trials/gemcitabine-oxaliplatin-gemox-vs-carboplatin-paclitaxel-cp-in-non-small-cell-lung-cancer-nsclc-54355https://curecurrent.com/trials/conventional-bronchoscopy-plus-rose-versus-electromagnetic-navigation-emn-plus-rose-in-small-peripheral-lesions-54356https://curecurrent.com/trials/study-of-picoplatin-efficacy-after-relapse-54357https://curecurrent.com/trials/evaluation-of-pemetrexed-combined-with-cisplatin-and-radiotherapy-for-unresectable-locally-advanced-non-small-cell-lung-54358https://curecurrent.com/trials/neulasta-in-subjects-with-advanced-non-small-cell-lung-cancer-nsclc-during-chemotherapy-54359https://curecurrent.com/trials/a-study-of-motexafin-gadolinium-mgd-in-combination-with-docetaxel-and-cisplatin-for-treatment-of-non-small-cell-lung-can-54360https://curecurrent.com/trials/effect-of-spacer-in-extrafine-formoterol-beclomethasone-treatment-to-asthma-54361https://curecurrent.com/trials/randomized-study-of-positron-emission-tomography-computed-tomography-pet-ct-in-pre-operative-staging-of-lung-cancer-54362https://curecurrent.com/trials/lung-cancer-informational-study-lcis-54363https://curecurrent.com/trials/mek-inhibitor-pd-325901-to-treat-advanced-non-small-cell-lung-cancer-54364https://curecurrent.com/trials/study-of-the-feasibility-to-derive-vaccine-from-tumor-tissue-in-patients-with-non-small-cell-lung-cancer-54365https://curecurrent.com/trials/radiolabeled-monoclonal-antibody-therapy-in-treating-patients-with-relapsed-or-refractory-non-small-cell-lung-cancer-54366https://curecurrent.com/trials/monoclonal-antibody-therapy-in-treating-patients-with-relapsed-or-refractory-small-cell-lung-cancer-54367https://curecurrent.com/trials/erlotinib-and-sorafenib-in-chemonaive-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-54368https://curecurrent.com/trials/study-of-safety-and-tolerability-of-intravenous-crs-207-in-adults-with-selected-advanced-solid-tumors-who-have-failed-or-54369https://curecurrent.com/trials/positron-emission-tomography-pet-computed-tomography-ct-and-roentgen-in-lung-cancer-evaluation-of-patients-in-general-pr-54370https://curecurrent.com/trials/study-of-concurrent-pemetrexed-cisplatin-and-radiotherapy-in-local-advanced-non-small-cell-lung-cancer-54371https://curecurrent.com/trials/vibration-response-imaging-vri-in-the-preoperative-management-in-patients-with-non-small-cell-lung-cancer-54372https://curecurrent.com/trials/pegfilgrastim-given-same-day-as-or-day-after-carboplatin-and-docetaxel-in-advanced-metastatic-non-small-cell-lung-cancer-54373https://curecurrent.com/trials/cpg-7909-injection-in-non-small-cell-lung-cancer-54374https://curecurrent.com/trials/chemotherapy-tirapazamine-and-radiation-therapy-in-treating-patients-with-non-small-cell-lung-cancer-54375https://curecurrent.com/trials/paclitaxel-carboplatin-and-radiation-therapy-with-or-without-adjuvant-paclitaxel-and-carboplatin-in-treating-patients-wi-54376https://curecurrent.com/trials/combination-chemotherapy-plus-radiation-therapy-in-treating-patients-with-small-cell-lung-cancer-54377https://curecurrent.com/trials/a-study-of-weekly-docetaxel-plus-cisplatin-followed-by-gemcitabine-vs-gemcitabine-plus-cisplatin-followed-by-weekly-doce-54378https://curecurrent.com/trials/combination-chemotherapy-and-radiation-therapy-in-treating-patients-with-stage-iii-non-small-cell-lung-cancer-that-canno-54379https://curecurrent.com/trials/gefitinib-in-treating-patients-with-stage-iiia-non-small-cell-lung-cancer-54380https://curecurrent.com/trials/chest-x-ray-or-chest-ct-scan-in-patients-at-high-risk-of-developing-lung-cancer-54381https://curecurrent.com/trials/celecoxib-or-observation-after-radiation-therapy-and-chemotherapy-in-treating-patients-with-stage-ii-or-stage-iii-non-sm-54382https://curecurrent.com/trials/alimta-and-gemcitabine-in-non-small-cell-lung-cancer-54383https://curecurrent.com/trials/role-of-pet-ct-in-determining-target-volumes-in-radiation-therapy-for-lung-cancer-54384https://curecurrent.com/trials/pentostatin-for-high-risk-and-refractory-chronic-graft-versus-host-disease-in-children-54385https://curecurrent.com/trials/multi-center-human-alert-trial-to-prevent-dvt-and-pe-54386https://curecurrent.com/trials/phase-ii-study-of-dmxaa-asa404-in-combination-with-chemotherapy-in-patients-with-advanced-non-small-cell-lung-cancer-54387https://curecurrent.com/trials/docetaxel-and-carboplatin-versus-docetaxel-as-second-line-treatment-in-patients-with-non-small-cell-lung-carcinoma-nsclc-54388https://curecurrent.com/trials/doxil-topotecan-doublet-cancer-study-54389https://curecurrent.com/trials/measles-vaccine-in-patients-with-measles-virus-positive-advanced-non-small-cell-lung-cancer-54390https://curecurrent.com/trials/topotecan-in-combination-with-pemetrexed-in-patients-with-advanced-malignancies-54391https://curecurrent.com/trials/picoplatin-as-second-line-therapy-for-patients-with-small-cell-lung-cancer-54392https://curecurrent.com/trials/fluorine-18-methyltyrosine-positron-emission-tomography-18f-fmt-pet-for-therapy-response-in-lung-cancer-54393https://curecurrent.com/trials/adrenal-function-in-patients-with-newly-diagnosed-lung-cancer-54394https://curecurrent.com/trials/acupuncture-for-post-thoracotomy-pain-54395https://curecurrent.com/trials/pharmocokinetic-pharmacodynamic-pk-pd-study-of-the-combination-cetuximab-gefitinib-54396https://curecurrent.com/trials/safety-and-efficacy-study-of-rhangiostatin-administered-in-combination-with-paclitaxel-and-carboplatin-to-patients-with-54397https://curecurrent.com/trials/mutations-in-the-epidermal-growth-factor-receptor-egfr-gene-in-non-small-cell-lung-carcinoma-nsclc-and-the-relation-to-r-54398https://curecurrent.com/trials/evaluation-of-the-overall-survival-of-meclinertant-versus-placebo-after-a-first-line-chemotherapy-with-cisplatin-etoposi-54399https://curecurrent.com/trials/sta-4783-in-combination-with-paclitaxel-and-carboplatin-for-the-treatment-of-chemotherapy-naive-patients-with-stage-iiib-54400https://curecurrent.com/trials/study-of-subcutaneous-campath-1h-in-patients-with-b-cell-cll-and-residual-disease-after-chemotherapy-54401https://curecurrent.com/trials/study-of-su011248-in-combination-with-docetaxel-in-patients-with-advanced-cancer-54402https://curecurrent.com/trials/randomized-trial-with-vinorelbine-and-gemcitabine-versus-docetaxel-and-gemcitabine-in-patients-with-non-small-cell-lung-54403https://curecurrent.com/trials/trial-of-docetaxel-versus-vinorelbine-as-1st-line-treatment-in-elderly-patients-with-non-small-cell-lung-cancer-nsclc-54404https://curecurrent.com/trials/phase-i-study-of-iressa-and-crt-imrt-in-chinese-patients-with-iiib-iv-nsclc-after-failure-of-platinum-based-chemotherapy-54405https://curecurrent.com/trials/study-of-su011248-in-patients-with-metastatic-non-small-cell-lung-cancer-54406https://curecurrent.com/trials/prospective-study-on-factors-predicting-chemo-radiotherapy-induced-pulmonary-and-esophageal-injury-54407https://curecurrent.com/trials/study-for-patients-who-have-benefited-and-tolerated-prior-panitumumab-treatment-54408https://curecurrent.com/trials/radioiodine-dosimetry-protocol-for-thyroid-cancer-metastases-54409https://curecurrent.com/trials/feasibility-study-of-cddp-cpt-11-psk-for-extensive-stage-disease-ed-small-cell-lung-cancer-54410https://curecurrent.com/trials/phase-ii-study-of-cetuximab-in-combination-with-carboplatin-and-docetaxel-for-patients-with-advanced-non-small-cell-lung-54411https://curecurrent.com/trials/study-of-motexafin-gadolinium-mgd-for-second-line-treatment-of-non-small-cell-lung-cancer-54412https://curecurrent.com/trials/a-study-of-subjects-with-previously-untreated-extensive-stage-small-cell-lung-cancer-sclc-treated-with-platinum-plus-eto-54413https://curecurrent.com/trials/protocol-for-primary-fractionated-stereotactic-body-radiation-therapy-for-stage-t1-t3n0-non-small-cell-lung-carcinoma-54414https://curecurrent.com/trials/gemcitabine-cisplatin-versus-gemcitabine-epirubicin-for-non-small-cell-lung-cancer-nsclc-54415https://curecurrent.com/trials/pilot-study-for-the-determination-of-tumor-response-to-chemotherapy-in-advanced-nsclc-through-gene-expression-profiling-54416https://curecurrent.com/trials/amiodarone-prophylaxis-for-atrial-fibrillation-in-patients-undergoing-surgery-for-lung-cancer-54417https://curecurrent.com/trials/budesonide-in-treating-former-and-current-smokers-with-bronchial-dysplasia-54418https://curecurrent.com/trials/imatinib-mesylate-and-chemotherapy-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-54419https://curecurrent.com/trials/gemcitabine-and-docetaxel-in-treating-patients-with-inoperable-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-54420https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-54421https://curecurrent.com/trials/bbr-3464-in-treating-patients-with-metastatic-small-cell-lung-cancer-that-has-not-responded-to-previous-treatment-54422https://curecurrent.com/trials/safety-and-efficacy-study-of-betamarc-to-treat-loss-of-weight-and-appetite-in-non-small-cell-lung-cancer-54423https://curecurrent.com/trials/saliva-mrna-expression-profiling-for-early-stage-non-small-cell-lung-cancer-screening-54424https://curecurrent.com/trials/effect-of-an-antioxidant-on-cancer-cachectic-patients-undergoing-exercise-training-54425https://curecurrent.com/trials/evaluation-of-thoracic-tumors-with-18f-fmt-and-18f-fdg-pet-ct-a-clinicopathological-study-54426https://curecurrent.com/trials/a-study-of-iressa-in-relapsed-and-refractory-small-cell-lung-cancer-54427https://curecurrent.com/trials/radiofrequency-ablation-of-pulmonary-tumors-response-evaluation-54428https://curecurrent.com/trials/the-impact-of-m1-m2-tumor-associated-macrophage-tam-polarization-on-cancer-progression-and-prognosis-prediction-54429https://curecurrent.com/trials/validation-of-coregistered-ct-pet-imaging-in-determining-tumor-volume-and-atelectasis-in-patients-with-operable-non-smal-54430https://curecurrent.com/trials/safety-study-of-radiotherapy-and-concurrent-erlotinib-tarceva-for-brain-metastases-from-a-non-small-cell-lung-cancer-54431https://curecurrent.com/trials/neoadjuvant-chemotherapy-plus-minus-surgery-in-non-small-cell-lung-cancer-nsclc-stage-iiia-n2-54432https://curecurrent.com/trials/study-of-oxaliplatin-and-gemcitabine-with-or-without-bevacizumab-to-treat-advanced-non-small-cell-lung-cancer-54433https://curecurrent.com/trials/transitoriness-in-cancer-patients-psychosocial-issues-in-cancer-care-54434https://curecurrent.com/trials/erlotinib-versus-carboplatin-vinorelbine-in-elderly-patients-with-advanced-non-small-cell-lung-cancer-nsclc-54435https://curecurrent.com/trials/histocompatibility-leukocyte-antigen-hla-a-0201-restricted-peptide-vaccine-therapy-in-patients-with-non-small-cell-lung-54436https://curecurrent.com/trials/histocompatibility-leukocyte-antigen-hla-a-2402-restricted-peptide-vaccine-therapy-in-patients-with-non-small-cell-lung-54437https://curecurrent.com/trials/angiogenesis-with-positron-emission-tomography-pet-tracer-uptake-54438https://curecurrent.com/trials/ph-i-bevacizumab-chemotherapy-in-pts-w-malig-pleural-effusion-due-to-adv-nsclc-54439https://curecurrent.com/trials/efficacy-of-erlotinib-for-brain-metastasis-of-non-small-cell-lung-cancer-54440https://curecurrent.com/trials/randomized-phase-iii-study-in-stage-iiib-and-iv-non-small-cell-lung-cancer-sequential-single-agent-vs-double-agent-vs-tr-54441https://curecurrent.com/trials/preoperative-twice-daily-chemoradiation-in-addition-to-chemotherapy-prior-to-surgery-in-stage-iii-non-small-cell-lung-ca-54442https://curecurrent.com/trials/three-combinations-of-docetaxel-and-irinotecan-for-recurrent-or-metastatic-non-small-cell-lung-cancer-54443https://curecurrent.com/trials/docetaxel-in-non-small-cell-lung-cancer-nsclc-54444https://curecurrent.com/trials/concurrent-helical-tomotherapy-with-chemotherapy-in-unresectable-stage-iii-non-small-cell-lung-cancer-nsclc-54445https://curecurrent.com/trials/study-of-alimta-pemetrexed-plus-velcade-bortezomib-or-alimta-alone-or-velcade-alone-in-patients-with-locally-advanced-or-54446https://curecurrent.com/trials/second-line-irinotecan-or-gefitinib-in-docetaxel-pretreated-nsclc-54447https://curecurrent.com/trials/weekly-versus-3-weekly-docetaxel-plus-cisplatin-for-advanced-nsclc-54448https://curecurrent.com/trials/topotecan-for-irinotecan-refractory-sclc-54449https://curecurrent.com/trials/phase-ii-trial-of-a-96-hour-continuous-infusion-of-paclitaxel-followed-by-cisplatin-for-patients-with-stage-iii-iv-and-r-54450https://curecurrent.com/trials/analysis-of-brain-metastasis-in-patients-with-lung-cancer-54451https://curecurrent.com/trials/treatment-of-pulmonary-sarcoidosis-with-pentoxifylline-54452https://curecurrent.com/trials/etanercept-to-treat-wegener-s-granulomatosis-54453https://curecurrent.com/trials/official-record-of-patients-diagnosed-with-lymphangioleiomyomatosis-lam-54454https://curecurrent.com/trials/phase-ii-neoadjuvant-trial-of-a-continuous-infusion-of-paclitaxel-plus-cisplatin-followed-by-chest-radiotherapy-for-pati-54455https://curecurrent.com/trials/diagnostic-effectiveness-of-virtual-bronchoscopy-54456https://curecurrent.com/trials/utility-of-endobronchial-ultrasound-in-the-investigation-of-suspected-lung-cancer-54457https://curecurrent.com/trials/study-of-developing-an-optimal-gemcitabine-based-regimen-to-treat-elderly-patients-with-advanced-non-small-cell-carcinom-54458https://curecurrent.com/trials/efficacy-of-gefitinib-for-brain-metastasis-of-non-small-cell-lung-cancer-54459https://curecurrent.com/trials/preoperative-percutaneous-radiofrequency-ablation-of-primary-and-secondary-lung-tumors-54460https://curecurrent.com/trials/phase-2-study-of-velcade-alone-or-velcade-plus-docetaxel-in-previously-treated-patients-with-advanced-non-small-cell-lun-54461https://curecurrent.com/trials/assess-the-variability-of-uni-dimensional-bi-dimensional-and-volumetric-ct-scan-measurement-of-non-small-cell-lung-cance-54462https://curecurrent.com/trials/a-study-to-evaluate-bevacizumab-and-chemotherapy-or-tarceva-in-treating-recurrent-or-refractory-nsclc-non-small-cell-lun-54463https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-who-are-undergoing-surgery-for-stage-ib-stage-ii-or-stage-iiia-non-small-cell-lung-54464https://curecurrent.com/trials/iscar-for-supplemental-care-in-stage-iv-lung-cancer-54465https://curecurrent.com/trials/study-of-tlk286-telcyta-vs-gefitinib-in-locally-advanced-or-metastatic-non-small-cell-lung-cancer-54466https://curecurrent.com/trials/cleansing-of-suction-blood-in-cardiac-surgery-for-reduced-inflammatory-response-54467https://curecurrent.com/trials/study-of-3d-radiotherapy-with-or-without-erlotinib-tarceva-in-patients-with-localized-non-small-cell-lung-cancer-54468https://curecurrent.com/trials/lucy-a-study-for-the-treatment-of-non-small-cell-lung-cancer-nsclc-in-patients-previously-treated-with-chemotherapy-54469https://curecurrent.com/trials/eus-fna-in-the-pre-operative-evaluation-of-patients-with-lung-cancer-54470https://curecurrent.com/trials/etanercept-for-wegener-s-granulomatosis-54471https://curecurrent.com/trials/a-cancer-vaccine-cg8123-given-with-and-without-cyclophosphamide-for-advanced-stage-non-small-cell-lung-cancer-nsclc-54472https://curecurrent.com/trials/abx-egf-in-combination-with-paclitaxel-and-carboplatin-for-the-treatment-of-advanced-non-small-cell-lung-cancer-nsclc-54473https://curecurrent.com/trials/treatment-for-patients-with-non-small-cell-lung-cancer-who-developed-anemia-due-to-chemotherapy-54474https://curecurrent.com/trials/bevacizumab-and-carboplatin-paclitaxel-and-radiation-in-non-small-cell-lung-cancer-54475https://curecurrent.com/trials/a-study-with-gemcitabine-cisplatin-and-ly293111-in-non-small-cell-lung-cancer-54476https://curecurrent.com/trials/phase-ii-iressa-irradiation-followed-by-chemo-in-nsclc-54477https://curecurrent.com/trials/zd1839-iressa-and-concurrent-chemo-radiation-in-patients-with-locally-advanced-non-small-cell-lung-cancer-54478https://curecurrent.com/trials/iressa-2nd-line-phase-iii-study-in-japan-54479https://curecurrent.com/trials/a-study-of-abt-751-in-patients-with-non-small-cell-lung-cancer-54480https://curecurrent.com/trials/efficacy-and-safety-of-cetuximab-in-combination-with-cisplatin-gemcitabine-as-first-line-therapy-in-advanced-nsclc-54481https://curecurrent.com/trials/alternating-cycles-of-carboplatin-gemcitabine-and-carboplatin-taxol-for-advanced-stage-nsclc-54482https://curecurrent.com/trials/a-trial-of-carboplatin-and-gemcitabine-versus-gemcitabine-alone-in-patients-with-non-small-cell-lung-cancer-54483https://curecurrent.com/trials/neo-adjuvant-gemcitabine-and-cisplatin-in-treating-patients-with-early-stage-of-non-small-cell-lung-cancer-54484https://curecurrent.com/trials/pulmonary-function-at-presentation-and-follow-up-in-hemato-oncology-3-7-years-old-children-54485https://curecurrent.com/trials/iscar-for-second-line-treatment-of-advanced-non-small-cell-lung-cancer-54486https://curecurrent.com/trials/subcutaneous-amifostine-ethyol-in-the-prevention-of-radiochemotherapy-induced-esophagitis-and-pneumonitis-in-patients-wi-54487https://curecurrent.com/trials/safety-and-effectiveness-of-abt-510-plus-combination-chemotherapy-in-subjects-with-non-small-cell-lung-cancer-nsclc-54488https://curecurrent.com/trials/a-study-of-the-safety-and-effects-of-adh-1-given-intravenously-as-a-single-agent-54489https://curecurrent.com/trials/iressa-as-a-first-line-treatment-in-chemonaive-patients-with-inoperable-non-small-cell-lung-cancer-54490https://curecurrent.com/trials/prevention-of-lung-edema-after-thoracic-surgery-54491https://curecurrent.com/trials/danish-lung-cancer-screening-trial-dlcst-54492https://curecurrent.com/trials/trial-of-perioperative-chemotherapy-gemcitabine-and-cisplatin-and-adjuvant-chemoradiotherapy-with-weekly-low-dose-gemcit-54493https://curecurrent.com/trials/trial-comparing-3-and-4-week-regimen-of-gemcitabine-and-cisplatin-in-patients-with-lung-cancer-54494https://curecurrent.com/trials/trial-of-pemetrexed-or-pemetrexed-with-gemcitabine-for-patients-with-advanced-lung-cancer-who-are-not-eligible-for-plati-54495https://curecurrent.com/trials/study-of-talabostat-and-docetaxel-in-advanced-non-small-cell-lung-cancer-54496https://curecurrent.com/trials/study-of-talabostat-docetaxel-versus-docetaxel-in-stage-iiib-iv-non-small-cell-lung-cancer-nsclc-after-failure-of-platin-54497https://curecurrent.com/trials/study-of-talabostat-and-pemetrexed-vs-pemetrexed-in-stage-iiib-iv-non-small-cell-lung-cancer-nsclc-after-failure-of-plat-54498https://curecurrent.com/trials/study-of-neurologic-progression-with-motexafin-gadolinium-and-radiation-therapy-smart-54499https://curecurrent.com/trials/study-of-dn101-and-taxotere-in-patients-with-advanced-non-small-cell-lung-cancer-54500https://curecurrent.com/trials/enzastaurin-as-second-and-third-line-treatment-for-non-small-cell-lung-cancer-54501https://curecurrent.com/trials/dalteparin-low-molecular-weight-heparin-for-primary-prophylaxis-of-venous-thromboembolism-in-brain-tumour-patients-54502https://curecurrent.com/trials/phase-ii-trial-of-tarceva-in-patients-with-non-small-cell-lung-cancer-54503https://curecurrent.com/trials/fluorine-18-methyltyrosine-positron-emission-tomography-for-diagnosis-and-staging-of-lung-cancer-54504https://curecurrent.com/trials/minimum-dose-ct-post-lung-biopsy-54505https://curecurrent.com/trials/safety-confirmation-study-of-pemetrexed-plus-cisplatin-in-patients-with-malignant-pleural-mesothelioma-54506https://curecurrent.com/trials/hypercoagulable-parameters-as-predictors-of-thrombotic-events-and-prognosis-in-patients-with-advanced-non-small-cell-lun-54507https://curecurrent.com/trials/oxaliplatin-cpt-11-for-extensive-stage-small-cell-lung-cancer-54508https://curecurrent.com/trials/analysis-of-tissues-from-patients-in-trial-of-myo-inositol-to-prevent-lung-cancer-54509https://curecurrent.com/trials/anesthesia-in-flexible-bronchoscopy-for-lung-cancer-diagnostic-54510https://curecurrent.com/trials/vats-lobectomy-for-clinical-stage-ib-or-ii-lung-cancer-54511https://curecurrent.com/trials/a-randomized-study-evaluating-the-feasibility-and-activity-of-three-different-combination-with-gemcitabine-as-first-line-54512https://curecurrent.com/trials/study-comparing-short-infusion-vs-fixed-dose-of-cisplatin-gemcitabine-in-non-small-cell-lung-cancer-54513https://curecurrent.com/trials/gemcitabine-platinum-containing-regimens-as-preoperative-chemotherapy-for-patients-with-non-small-cell-lung-cancer-54514https://curecurrent.com/trials/a-single-arm-phase-2-study-of-pemetrexed-as-2nd-line-treatment-of-advanced-non-small-cell-lung-cancer-54515https://curecurrent.com/trials/safety-and-pharmacokinetics-of-jin-fu-kang-in-comb-w-docetaxel-for-patients-w-non-small-cell-lung-cancer-54516https://curecurrent.com/trials/pemetrexed-plus-gemcitabine-for-patients-with-locally-advanced-or-metastatic-nsclc-who-have-not-had-previous-chemotherap-54517https://curecurrent.com/trials/a-study-of-pemetrexed-in-small-cell-lung-cancer-which-has-returned-54518https://curecurrent.com/trials/efficacy-trial-of-gemcitabine-containing-regimens-as-preoperative-chemotherapy-in-non-small-cell-lung-cancer-54519https://curecurrent.com/trials/pemetrexed-and-gemcitabine-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-54520https://curecurrent.com/trials/protocol-for-radiofrequency-ablation-of-pulmonary-neoplasms-54521https://curecurrent.com/trials/the-dante-trial-a-randomized-study-on-lung-cancer-screening-with-low-dose-spiral-computed-tomography-54522https://curecurrent.com/trials/a-study-to-evaluate-the-single-agent-lenalidomide-in-subjects-with-recurrent-non-small-cell-lung-cancer-54523https://curecurrent.com/trials/safety-and-immunogenicity-of-recombinant-dna-and-adenovirus-expressing-l523s-protein-in-early-stage-non-small-cell-lung-54524https://curecurrent.com/trials/randomized-trial-of-fluticasone-in-bronchial-premalignancy-54525https://curecurrent.com/trials/voriconazole-or-placebo-in-the-prophylaxis-of-lung-infiltrates-in-patients-undergoing-induction-chemotherapy-for-acute-m-54526https://curecurrent.com/trials/a-clinical-efficacy-study-of-an-oral-tyrosine-kinase-inhibitor-of-vegfr-2-given-in-combination-with-chemotherapy-54527https://curecurrent.com/trials/a-phase-2-randomized-open-label-study-of-single-agent-ci-1033-in-patients-with-advanced-non-small-cell-lung-cancer-54528https://curecurrent.com/trials/ph-1-evaluation-of-oral-ci-1033-in-combination-with-paclitaxel-carboplatin-as-1st-line-chemotherapy-in-nsclc-patients-54529https://curecurrent.com/trials/the-role-of-the-vagus-nerve-in-tumor-to-brain-communication-in-lung-cancer-patients-54530https://curecurrent.com/trials/study-for-patients-with-non-small-cell-lung-cancer-nsclc-54531https://curecurrent.com/trials/bronchial-ultrasonography-via-a-fibrescope-pilot-study-in-tumoral-disease-54532https://curecurrent.com/trials/the-utility-and-cost-effectiveness-analysis-of-18f-fdg-petin-staging-potential-operable-non-small-cell-lung-cancer-54533https://curecurrent.com/trials/gemcitabine-in-combination-with-cisplatin-as-neoadjuvant-nsclc-chemotherapy-54534https://curecurrent.com/trials/alimta-pemetrexed-cisplatin-and-alimta-pemetrexed-carboplatin-in-extensive-stage-small-cell-lung-cancer-54535https://curecurrent.com/trials/comparing-3-schedules-of-alimta-plus-gemzar-54536https://curecurrent.com/trials/a-phase-3-trial-of-ly900003-plus-gemcitabine-and-cisplatin-versus-gemcitabine-and-cisplatin-in-patients-with-advanced-pr-54537https://curecurrent.com/trials/alimta-plus-carboplatin-as-front-line-chemotherapy-for-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-54538https://curecurrent.com/trials/a-phase-2-trial-of-antisense-nucleotide-to-pkc-alpha-ly900003-isis-3521-plus-gemcitabine-and-carboplatin-in-patients-wit-54539https://curecurrent.com/trials/first-line-egfr-1-tyrosine-kinase-inhibition-in-patients-with-nsclc-with-mutant-egfr-gene-54540https://curecurrent.com/trials/study-of-dn-101-calcitriol-and-docetaxel-in-subjects-previously-enrolled-in-studies-dn101-002-or-dn101-004-54541https://curecurrent.com/trials/tnf-alpha-in-refractory-asthma-54542https://curecurrent.com/trials/study-to-determine-the-efficacy-of-bendamustin-in-patients-with-recurrent-small-cell-lung-cancer-sclc-54543https://curecurrent.com/trials/inhaled-doxorubicin-plus-iv-docetaxel-and-cisplatin-in-patients-with-non-small-cell-lung-carcinoma-nsclc-54544https://curecurrent.com/trials/development-of-tuberculosis-diagnostic-kit-54545https://curecurrent.com/trials/biomarkers-of-benzene-exposure-in-inner-city-residents-54546https://curecurrent.com/trials/the-serum-tissue-factor-level-in-lung-cancer-patients-as-a-prognostic-factor-54547https://curecurrent.com/trials/comparison-study-of-wbrt-and-srs-alone-versus-with-temozolomide-or-erlotinib-in-patients-with-brain-metastases-of-nsclc-54548https://curecurrent.com/trials/a-study-for-small-cell-lung-cancer-sclc-in-extensive-disease-stage-54549https://curecurrent.com/trials/phase-iii-study-of-docetaxel-vs-vinorelbine-in-elderly-patients-with-advanced-non-small-cell-lung-cancer-54550https://curecurrent.com/trials/a-phase-randomized-study-of-mitomycin-vindesine-cisplatin-versus-irinotecan-carboplatin-versus-paclitaxel-carboplatin-wi-54551https://curecurrent.com/trials/phase-iii-study-of-gemcitabine-compared-with-uft-in-patients-with-completely-resected-pathological-stage-ib-iiia-non-sma-54552https://curecurrent.com/trials/random-trial-for-elderly-patients-with-nsclc-54553https://curecurrent.com/trials/study-of-carboplatin-gemcitabine-plus-bevacizumab-in-advanced-lung-cancer-54554https://curecurrent.com/trials/methylation-status-of-cd44-promoter-region-in-primary-lung-cancer-54555https://curecurrent.com/trials/risk-factors-of-radiation-pneumonitis-54556https://curecurrent.com/trials/serpin-d1-and-its-role-in-lung-cancer-invasion-and-metastasis-54557https://curecurrent.com/trials/previously-untreated-advanced-non-small-cell-lung-cancer-nsclc-54558https://curecurrent.com/trials/phase-i-open-label-dose-escalation-study-to-determine-the-maximum-tolerated-dose-and-to-evaluate-the-safety-profile-of-l-54559https://curecurrent.com/trials/phase-ii-study-of-oxaliplatin-and-navelbine-for-second-line-treatment-of-advanced-nsclc-54560https://curecurrent.com/trials/toxicities-associated-with-subcutaneous-administration-of-ethyol-amifostine-for-the-prevention-of-radiation-induced-toxi-54561https://curecurrent.com/trials/adjuvant-celecoxib-in-completely-resected-pn1-2-nsclc-patients-54562https://curecurrent.com/trials/sleep-disturbance-in-lung-cancer-patients-54563https://curecurrent.com/trials/differentiation-of-malig-ben-solitary-pulm-nodules-prediction-of-clin-outcome-using-perfus-analysis-of-dcemri-54564https://curecurrent.com/trials/a-phase-iib-trial-of-pulmicort-turbuhaler-budesonide-54565https://curecurrent.com/trials/molecular-mechanism-of-trophinin-in-cancer-invasion-and-metastasis-54566https://curecurrent.com/trials/subcutaneous-amifostine-safety-study-54567https://curecurrent.com/trials/a-randomized-phase-iii-trial-of-chemotherapy-alone-versus-chemotherapy-followed-by-gefitinib-in-stage-iiib-iv-non-small-54568https://curecurrent.com/trials/comparative-trial-of-pivanex-and-docetaxel-vs-docetaxel-monotherapy-in-patients-with-advanced-non-small-cell-lung-cancer-54569https://curecurrent.com/trials/modulation-of-benzene-metabolism-by-exposure-to-environment-54570https://curecurrent.com/trials/study-of-111in-dac-as-an-medical-imaging-agent-for-lung-cancer-and-brain-cancer-consistent-with-metastatic-lung-cancer-54571https://curecurrent.com/trials/dapsone-100-mg-versus-50-as-primary-prophylaxis-for-pneumocystis-carinii-pneumonia-pcp-in-patients-with-aids-related-com-54572https://curecurrent.com/trials/phase-i-dose-escalation-study-of-velcade-plus-docetaxel-in-patients-with-advanced-non-small-cell-lung-cancer-or-other-so-54573https://curecurrent.com/trials/utility-of-anatometabolic-imaging-for-radiation-treatment-planning-for-lung-cancer-54574https://curecurrent.com/trials/ryz711-diagnostic-platform-study-54575https://curecurrent.com/trials/a-study-testing-if-patients-with-advanced-prostate-cancer-who-are-responding-well-to-combination-treatment-can-safely-re-54576https://curecurrent.com/trials/safety-pharmacokinetics-and-preliminary-efficacy-of-vir-5500-amx-500-in-prostate-cancer-54577https://curecurrent.com/trials/older-men-s-decision-making-about-active-surveillance-for-prostate-cancer-aim-3-decision-aid-cognitive-and-usability-tes-54578https://curecurrent.com/trials/social-determinants-of-migrant-health-factors-impacting-prostate-cancer-care-and-survivorship-among-sub-saharan-african-54579https://curecurrent.com/trials/impact-of-fluciclovine-18f-pet-positron-emission-tomography-on-the-management-of-prostate-cancer-following-negative-or-e-54580https://curecurrent.com/trials/radiation-medication-radium-223-dichloride-versus-radium-223-dichloride-plus-radiation-enhancing-medication-m3814-versus-54581https://curecurrent.com/trials/testing-the-effectiveness-of-two-immunotherapy-drugs-nivolumab-and-ipilimumab-with-one-anti-cancer-targeted-drug-cabozan-54582https://curecurrent.com/trials/lutetium-177lu-dgul-combined-with-pembrolizumab-in-metastatic-castration-resistant-prostate-cancer-54583https://curecurrent.com/trials/methylphenidate-and-exercise-in-reducing-cancer-related-fatigue-in-patients-with-prostate-cancer-54584https://curecurrent.com/trials/neoadjuvant-adt-darolutamide-with-pembrolizumab-followed-by-adjuvant-pembrolizumab-in-molecularly-stratified-high-risk-p-54585https://curecurrent.com/trials/fog-001-in-locally-advanced-or-metastatic-solid-tumors-54586https://curecurrent.com/trials/docetaxel-and-sx-682-in-recurrent-metastatic-head-and-neck-squamous-cell-carcinoma-salivary-gland-carcinoma-and-advanced-54587https://curecurrent.com/trials/a-trial-on-fezolinetant-for-vasomotor-symptoms-in-men-receiving-androgen-deprivation-therapy-adt-54588https://curecurrent.com/trials/predictive-factors-for-response-to-lutetium-177-psma-radioligand-therapy-in-patients-with-metastatic-castration-resistan-54589https://curecurrent.com/trials/testing-the-safety-and-effectiveness-of-radiation-based-treatment-lutetium-lu-177-dotatate-for-metastatic-prostate-cance-54590https://curecurrent.com/trials/bright-white-light-therapy-in-reducing-cancer-related-fatigue-and-depression-in-advanced-prostate-cancer-patients-underg-54591https://curecurrent.com/trials/men-at-high-genetic-risk-for-prostate-cancer-54592https://curecurrent.com/trials/multitargeted-recombinant-ad5-psa-muc-1-brachyury-based-immunotherapy-triadeno-vaccine-with-il-15-superagonist-n-803-in-54593https://curecurrent.com/trials/abiraterone-acetate-prednisone-and-apalutamide-in-treating-patients-with-hormone-naive-metastatic-prostate-cancer-54594https://curecurrent.com/trials/fusion-guided-focal-laser-ablation-of-prostate-cancer-54595https://curecurrent.com/trials/also-perform-study-alternating-stereotaxic-or-pelvic-radiotherapy-for-metachronic-metastatic-prostate-cancer-54596https://curecurrent.com/trials/abiraterone-acetate-and-antiandrogen-therapy-with-or-without-cabazitaxel-and-prednisone-in-treating-patients-with-metast-54597https://curecurrent.com/trials/an-investigational-scan-mri-with-dixon-based-sequences-in-detecting-prostate-cancer-54598https://curecurrent.com/trials/a-study-evaluating-the-safety-pharmacokinetics-and-preliminary-activity-of-gdc-1261-in-participants-with-advanced-or-met-54599https://curecurrent.com/trials/testing-pasritamig-before-surgery-for-the-treatment-of-localized-prostate-cancer-54600https://curecurrent.com/trials/a-study-to-test-inavolisib-treatment-in-participants-with-metastatic-castration-resistant-prostate-cancer-54601https://curecurrent.com/trials/multicenter-prospective-observational-study-on-prostate-salvage-using-high-dose-rate-brachytherapy-54602https://curecurrent.com/trials/walnuts-for-power-polyphenols-omega-3-fatty-acids-weight-loss-and-energy-54603https://curecurrent.com/trials/multi-peptide-vaccination-and-bispecific-psmaxcd3-antibody-treatment-in-patients-with-prostate-cancer-54604https://curecurrent.com/trials/study-of-opevesostat-mk-5684-versus-alternative-nha-in-mcrpc-mk-5684-003-54605https://curecurrent.com/trials/an-observational-study-to-learn-more-about-treatment-patterns-and-factors-determining-the-choice-of-treatment-in-canadia-54606https://curecurrent.com/trials/a-study-to-learn-about-the-outcomes-between-study-medicines-enzalutamide-and-darolutamide-among-men-with-metastatic-cast-54607https://curecurrent.com/trials/pluvicto-for-the-treatment-of-african-american-men-with-metastatic-castration-resistant-prostate-cancer-54608https://curecurrent.com/trials/novel-synthetic-t2w-mr-imaging-and-spin-parameter-mapping-techniques-for-screening-prostate-cancer-54609https://curecurrent.com/trials/the-effect-of-multidisciplinary-care-approach-on-cv-risk-modification-in-cap-patients-receiving-adt-54610https://curecurrent.com/trials/combining-ipilimumab-with-abiraterone-acetate-plus-prednisone-in-chemotherapy-and-immunotherapy-na-ve-patients-with-prog-54611https://curecurrent.com/trials/a-study-of-opevesostat-mk-5684-versus-alternative-next-generation-hormonal-agent-nha-in-metastatic-castration-resistant-54612https://curecurrent.com/trials/a-study-of-darolutamide-plus-androgen-deprivation-therapy-in-patients-with-metastatic-hormone-sensitive-prostate-cancer-54613https://curecurrent.com/trials/identifying-the-best-follow-up-approach-for-people-who-have-had-treatment-to-cure-newly-diagnosed-prostate-cancer-54614https://curecurrent.com/trials/a-study-evaluating-the-safety-pharmacokinetics-and-activity-of-ro7656594-in-participants-with-advanced-or-metastatic-pro-54615https://curecurrent.com/trials/iccare-project-4-grounded-theory-study-of-the-social-determinants-of-migrant-health-factors-impacting-prostate-cancer-ca-54616https://curecurrent.com/trials/fpi-2265-225ac-psma-i-t-and-olaparib-for-patients-with-metastatic-castration-resistant-prostate-cancer-mcrpc-54617https://curecurrent.com/trials/a-clinical-study-of-ifinatamab-deruxtecan-based-treatment-combinations-or-as-monotherapy-to-treat-metastatic-castrate-re-54618https://curecurrent.com/trials/substudy-01a-safety-and-efficacy-of-opevesostat-mk-5684-based-treatment-combinations-or-opevesostat-alone-in-participant-54619https://curecurrent.com/trials/a-randomized-pragmatic-study-of-ct-versus-mri-based-planning-for-high-dose-rate-prostate-brachytherapy-for-prostate-canc-54620https://curecurrent.com/trials/a-clinical-study-of-ifinatamab-deruxtecan-i-dxd-in-people-with-metastatic-prostate-cancer-mk-2400-001-54621https://curecurrent.com/trials/comprehensive-assessment-of-cancer-theranostic-response-54622https://curecurrent.com/trials/il-15-superagonist-with-or-without-vaccine-in-biochemically-recurrent-prostate-cancer-after-previous-stereotactic-body-r-54623https://curecurrent.com/trials/risk-adapt-protocol-in-metastatic-hormone-sensitive-prostate-cancer-mhspc-54624https://curecurrent.com/trials/application-of-ultrasound-radiomics-in-ultrasound-fusion-targeted-prostate-biopsy-54625https://curecurrent.com/trials/ac-225-psma-62-trial-in-oligometastatic-hormone-sensitive-and-metastatic-castration-resistant-prostate-cancer-54626https://curecurrent.com/trials/the-influence-of-music-on-perceived-pain-and-levels-of-anxiety-while-undergoing-transperineal-prostate-biopsy-the-vivald-54627https://curecurrent.com/trials/an-acupuncture-study-for-prostate-cancer-survivors-with-urinary-issues-54628https://curecurrent.com/trials/a-study-to-learn-about-the-investigational-drug-rinzimetostat-oric-944-in-patients-with-mcrpc-who-were-previously-treate-54629https://curecurrent.com/trials/ascvd-management-using-ccta-in-prostate-cancer-patients-on-adt-54630https://curecurrent.com/trials/study-of-ar-suppression-with-carotuximab-in-metastatic-castration-resistant-prostate-canc-54631https://curecurrent.com/trials/high-cardiovascular-risk-intervention-with-cardio-oncology-consultation-for-prostate-cancer-following-androgen-receptor-54632https://curecurrent.com/trials/comparing-moderately-and-ultra-hypofractionated-radiation-treatments-for-prostate-cancer-54633https://curecurrent.com/trials/a-single-arm-phase-ii-study-of-neoadjuvant-intensified-androgen-deprivation-leuprolide-and-abiraterone-acetate-in-combin-54634https://curecurrent.com/trials/long-term-follow-up-in-patients-with-prostate-cancer-after-surgery-54635https://curecurrent.com/trials/a-study-of-bms986365-in-combination-with-degarelix-in-people-with-prostate-cancer-54636https://curecurrent.com/trials/a-study-of-gsk5458514-administered-alone-or-in-combination-with-other-anti-cancer-agents-in-participants-with-prostate-c-54637https://curecurrent.com/trials/increasing-the-dose-of-survivorship-care-planning-in-improving-care-and-outcomes-in-prostate-cancer-survivors-receiving-54638https://curecurrent.com/trials/psma-mri-guided-prostate-sbrt-argos-comprehensive-longitudinal-evaluation-of-imaging-biomarkers-post-radiotherapy-climbe-54639https://curecurrent.com/trials/focal-versus-whole-gland-high-dose-rate-brachytherapy-hdr-bt-boost-to-external-beam-radiotherapy-in-localized-prostate-c-54640https://curecurrent.com/trials/effect-of-cyclic-sighing-breathing-exercise-on-crbd-pain-and-sleep-quality-in-patients-undergoing-tur-54641https://curecurrent.com/trials/effects-of-hypopressive-exercises-on-urinary-incontinence-and-erectile-dysfunction-after-radical-prostatectomy-54642https://curecurrent.com/trials/evaluating-an-alternative-clinical-genetics-cancer-care-delivery-model-a-pilot-study-of-patient-outcomes-54643https://curecurrent.com/trials/talazoparib-plus-enzalutamide-after-progression-to-prior-arpi-in-metastatic-prostate-cancer-54644https://curecurrent.com/trials/targeted-treatment-for-metastatic-prostate-cancer-the-predict-trial-54645https://curecurrent.com/trials/phase-3-study-of-prostatak-immunotherapy-with-standard-radiation-therapy-for-localized-prostate-cancer-54646https://curecurrent.com/trials/evaluation-of-neuromuscular-electrostimulation-in-addition-to-a-physical-activity-program-54647https://curecurrent.com/trials/randomized-controlled-trial-of-can-2409-immunotherapy-during-active-surveillance-for-prostate-cancer-ulysses-54648https://curecurrent.com/trials/testing-different-dosing-schedules-of-the-anti-cancer-drug-lutetium-177lu-psma-rlt-and-its-effect-on-patients-with-advan-54649https://curecurrent.com/trials/imaging-studies-to-check-the-local-response-of-prostate-cancer-to-radiation-therapy-54650https://curecurrent.com/trials/a-prolonged-nightly-fasting-for-men-on-adt-for-pca-54651https://curecurrent.com/trials/jur-003-in-adult-patients-with-metastatic-prostate-cancer-54652https://curecurrent.com/trials/a-trial-to-learn-how-safe-azd9750-is-and-how-well-it-works-in-people-with-metastatic-prostate-cancer-when-given-with-or-54653https://curecurrent.com/trials/study-evaluating-dosimetry-randomized-dose-optimization-dose-escalation-and-efficacy-of-ac-225-rosopatamab-tetraxetan-in-54654https://curecurrent.com/trials/high-dose-rate-brachytherapy-and-stereotactic-body-radiation-therapy-in-treating-patients-with-prostate-cancer-54655https://curecurrent.com/trials/cabazitaxel-carboplatin-vs-177lu-psma-617-in-metastatic-castrate-resistant-prostate-cancer-54656https://curecurrent.com/trials/testing-the-addition-of-docetaxel-chemotherapy-to-the-usual-treatment-hormonal-therapy-and-apalutamide-for-metastatic-pr-54657https://curecurrent.com/trials/development-of-an-intraoperative-adaptive-biopsy-system-for-prostate-cancer-integrating-imaging-navigation-with-metaboli-54658https://curecurrent.com/trials/a-study-of-risvutatug-rezetecan-in-participants-with-metastatic-castration-resistant-prostate-cancer-mcrpc-embold-prosta-54659https://curecurrent.com/trials/collection-of-blood-from-patients-with-prostate-cancer-54660https://curecurrent.com/trials/pet-mr-psa-prostate-cancer-recidive-study-54661https://curecurrent.com/trials/radiation-therapy-with-rapidplan-knowledge-based-planning-vs-human-driven-planning-for-treatment-of-prostate-cancer-54662https://curecurrent.com/trials/evaluation-of-hifu-hemiablation-and-short-term-androgen-deprivation-therapy-combination-to-enhance-prostate-cancer-contr-54663https://curecurrent.com/trials/a-phase-ib-ii-open-label-study-of-amo959-with-lutetium-177lu-vipivotide-tetraxetan-aaa617-in-combination-with-arpi-in-ad-54664https://curecurrent.com/trials/testing-the-use-of-high-dose-testosterone-followed-by-darolutamide-compared-to-the-usual-care-for-patients-with-metastat-54665https://curecurrent.com/trials/an-external-control-arm-study-comparing-survival-among-metastatic-castration-resistant-prostate-cancer-mcrpc-patients-tr-54666https://curecurrent.com/trials/radiation-therapy-with-or-without-apalutamide-in-treating-patients-with-recurrent-prostate-cancer-the-balance-trial-54667https://curecurrent.com/trials/pet-ct-characterization-of-treatment-resistance-54668https://curecurrent.com/trials/linking-in-with-advice-and-supports-for-men-impacted-by-metastatic-cancer-54669https://curecurrent.com/trials/chemical-shift-encoded-mri-for-active-bone-marrow-dosimetry-in-radiopharmaceutical-therapy-54670https://curecurrent.com/trials/hypofractionated-whole-pelvis-radiotherapy-wprt-vs-conventionally-fractionated-wprt-in-prostate-cancer-54671https://curecurrent.com/trials/a-phase-3-study-of-177lu-ludotadipep-for-metastatic-castration-resistant-prostate-cancer-54672https://curecurrent.com/trials/understanding-the-role-of-mycaregorithm-as-a-visual-digital-platforms-in-cancer-treatment-education-and-patient-comprehe-54673https://curecurrent.com/trials/efficacy-study-of-switching-to-a-lutenizing-hormone-releasing-hormone-lhrh-antagonist-from-a-lhrh-agonist-to-treat-progr-54674https://curecurrent.com/trials/androgen-deprivation-with-or-without-ptvg-ar-and-with-or-without-t-cell-checkpoint-blockade-in-patients-with-newly-diagn-54675https://curecurrent.com/trials/hemodynamic-effects-of-trendelenburg-position-and-pneumoperitoneum-in-urologic-robotic-surgery-54676https://curecurrent.com/trials/a-novel-imaging-protocol-in-use-to-identify-lymph-nodes-and-organs-of-interest-54677https://curecurrent.com/trials/regn21353-alone-or-in-combination-with-nezastomig-for-metastatic-castration-resistant-prostate-cancer-in-adult-participa-54678https://curecurrent.com/trials/brief-title-introspect-intraoperative-psma-pet-ct-imaging-during-radical-prostatectomy-54679https://curecurrent.com/trials/addressing-health-literacy-with-a-tailored-survivorship-care-plan-54680https://curecurrent.com/trials/evaluation-of-atherosclerotic-plaques-in-abdominal-ct-studies-54681https://curecurrent.com/trials/a-study-to-compare-the-efficacy-and-safety-of-bms-986365-versus-the-investigator-s-choice-of-therapy-in-participants-wit-54682https://curecurrent.com/trials/concomitant-trans-perineal-prostate-biopsy-and-ablation-bioblation-for-prostate-cancer-54683https://curecurrent.com/trials/safety-and-efficacy-of-psma-targeted-fluorescent-contrast-agent-dgpr1008-for-intraoperative-imaging-in-robot-assisted-ra-54684https://curecurrent.com/trials/autonomic-and-renal-contributions-to-hypertension-with-adt-54685https://curecurrent.com/trials/talazoparib-enzalutamide-vs-enzalutamide-monotherapy-in-mcrpc-54686https://curecurrent.com/trials/study-of-18f-florastamin-pet-ct-imaging-in-patients-with-at-least-intermediate-risk-prostate-cancer-54687https://curecurrent.com/trials/tractography-guided-nerve-sparing-in-prostate-cancer-54688https://curecurrent.com/trials/hypo-fractionated-radiation-therapy-with-or-without-androgen-suppression-for-intermediate-risk-prostate-cancer-54689https://curecurrent.com/trials/periprostatic-neurolysis-in-prostate-cancer-54690https://curecurrent.com/trials/urolift-pre-sbrt-for-reduced-urinary-toxicity-in-patients-with-bph-and-prostate-cancer-54691https://curecurrent.com/trials/an-investigational-scan-flotufolastat-f-18-pet-ct-for-detecting-residual-or-recurrent-disease-in-patients-who-completed-54692https://curecurrent.com/trials/real-time-fluorescence-microscopy-for-intraoperative-assessment-of-prostate-biopsy-cores-flash-54693https://curecurrent.com/trials/a-single-arm-blinded-fluorescent-psma-histopathology-trial-of-as1986ns-54694https://curecurrent.com/trials/building-community-living-labs-in-black-communities-to-advance-prostate-health-equity-and-reduce-prostate-cancer-dispari-54695https://curecurrent.com/trials/study-of-hypo-fractionated-proton-radiation-for-low-risk-prostate-cancer-54696https://curecurrent.com/trials/safety-and-efficacy-of-oral-testosterone-undecanoate-followed-by-enzalutamide-as-therapy-for-men-with-metastatic-castrat-54697https://curecurrent.com/trials/tulmistar-02-a-phase-i-ii-open-label-study-of-tulmimetostat-in-combination-with-darolutamide-vs-darolutamide-and-tulmime-54698https://curecurrent.com/trials/darolutamide-in-addition-to-adt-versus-adt-in-metastatic-hormone-sensitive-prostate-cancer-54699https://curecurrent.com/trials/molecular-imaging-informed-radiation-dose-escalation-to-sites-of-recurrent-disease-and-de-escalation-to-uninvolved-areas-54700https://curecurrent.com/trials/a-study-of-apalutamide-jnj-56021927-arn-509-plus-androgen-deprivation-therapy-adt-versus-adt-in-participants-with-mhspc-54701https://curecurrent.com/trials/prostate-cancer-risk-identification-in-a-multi-ethnic-cohort-a-prospective-us-based-multi-center-validation-study-of-pro-54702https://curecurrent.com/trials/precision-based-genomics-in-prostate-cancer-54703https://curecurrent.com/trials/a-study-of-niraparib-combination-therapies-for-the-treatment-of-metastatic-castration-resistant-prostate-cancer-54704https://curecurrent.com/trials/cancer-oriented-understanding-and-navigation-via-supportive-and-educational-language-models-counsel-54705https://curecurrent.com/trials/a-study-of-jnj-87189401-combined-with-jnj-78278343-for-advanced-prostate-cancer-54706https://curecurrent.com/trials/prostate-olaparib-real-world-evidence-study-54707https://curecurrent.com/trials/integrated-genomic-prostate-score-with-mri-targeted-prostate-biopsies-54708https://curecurrent.com/trials/barrigel-pprt-post-prostatectomy-radiation-therapy-trial-54709https://curecurrent.com/trials/a-study-of-apalutamide-arn-509-in-men-with-non-metastatic-castration-resistant-prostate-cancer-54710https://curecurrent.com/trials/an-efficacy-and-safety-study-of-apalutamide-jnj-56021927-in-combination-with-abiraterone-acetate-and-prednisone-versus-a-54711https://curecurrent.com/trials/bintrafusp-alfa-m7824-and-pds01adc-alone-and-in-combination-with-stereotactic-body-radiation-therapy-sbrt-in-adults-with-54712https://curecurrent.com/trials/dose-escalation-study-evaluating-safety-of-therasphere-prostate-cancer-pca-device-54713https://curecurrent.com/trials/cascadediagnose-prostate-mri-54714https://curecurrent.com/trials/a-study-of-niraparib-in-combination-with-abiraterone-acetate-and-prednisone-versus-abiraterone-acetate-and-prednisone-fo-54715https://curecurrent.com/trials/arx517-jnj-95298177-as-monotherapy-or-combination-therapy-in-subjects-with-metastatic-prostate-cancer-54716https://curecurrent.com/trials/a-study-of-jnj-69086420-an-actinium-225-labeled-antibody-targeting-human-kallikrein-2-hk2-for-advanced-prostate-cancer-54717https://curecurrent.com/trials/efficacy-and-safety-of-pembrolizumab-mk-3475-plus-enzalutamide-plus-androgen-deprivation-therapy-adt-versus-placebo-plus-54718https://curecurrent.com/trials/study-of-pembrolizumab-mk-3475-plus-enzalutamide-versus-placebo-plus-enzalutamide-in-participants-with-metastatic-castra-54719https://curecurrent.com/trials/regn15505-psmax4-1bb-alone-or-in-combination-with-cemiplimab-or-regn4336-psmaxcd3-in-adult-patients-with-metastatic-cast-54720https://curecurrent.com/trials/study-of-18f-florastamin-pet-ct-imaging-in-patients-with-suspected-recurrence-of-prostate-cancer-54721https://curecurrent.com/trials/a-rollover-study-for-continued-study-treatment-and-ongoing-safety-monitoring-54722https://curecurrent.com/trials/a-study-of-comparative-formulations-of-niraparib-and-abiraterone-acetate-aa-in-men-with-prostate-cancer-54723https://curecurrent.com/trials/a-study-of-gsk5764227-in-combination-with-standard-of-care-soc-or-other-agents-in-participants-with-advanced-solid-tumor-54724https://curecurrent.com/trials/study-of-azd0516-as-monotherapy-and-in-combination-in-participants-with-metastatic-prostate-cancer-54725https://curecurrent.com/trials/a-study-of-jnj-56021927-arn-509-and-abiraterone-acetate-in-participants-with-metastatic-castration-resistant-prostate-ca-54726https://curecurrent.com/trials/a-study-of-pasritamig-with-or-without-jnj-87189401-versus-placebo-for-late-line-metastatic-castration-resistant-prostate-54727https://curecurrent.com/trials/a-study-of-pasritamig-jnj-78278343-in-combination-with-other-agents-for-metastatic-prostate-cancer-54728https://curecurrent.com/trials/evaluation-of-a-prostate-targeted-pet-imaging-system-p-pet-for-detecting-prostate-cancer-54729https://curecurrent.com/trials/modified-saddle-block-vs-spinal-anesthesia-for-turp-54730https://curecurrent.com/trials/a-study-of-jnj-78278343-in-combination-with-jnj-95298177-for-treatment-of-prostate-cancer-54731https://curecurrent.com/trials/a-point-of-prostate-cancer-diagnosis-virtual-reality-assistant-intervention-in-supporting-newly-diagnosed-black-men-54732https://curecurrent.com/trials/the-cardiovascular-risk-evaluation-in-men-with-prostate-cancer-study-care-pc-pilot-feasibility-study-54733https://curecurrent.com/trials/non-invasive-biomarkers-in-prostate-cancer-disease-management-54734https://curecurrent.com/trials/phase-1-study-of-ace-232-to-treat-patients-with-metastatic-castration-resistant-prostate-cancer-54735https://curecurrent.com/trials/a-study-of-pasritamig-jnj-78278343-in-combination-with-jnj-86974680-for-treatment-of-prostate-cancer-54736https://curecurrent.com/trials/a-study-of-jnj-101556143-in-participants-with-metastatic-prostate-cancer-54737https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-multiple-doses-of-jnj-56021927-on-the-pharmacokinetics-of-multiple-cytochrome-p450-and-54738https://curecurrent.com/trials/decision-support-tool-to-enhance-germline-genetic-testing-for-patients-with-prostate-cancer-54739https://curecurrent.com/trials/a-study-of-adding-apalutamide-to-radiotherapy-and-lhrh-agonist-in-high-risk-patients-with-hormone-sensitive-prostate-can-54740https://curecurrent.com/trials/study-of-hld-0915-jnj-101556143-in-patients-with-metastatic-prostate-cancer-54741https://curecurrent.com/trials/study-of-adxs-504-immunotherapy-for-recurrent-prostate-cancer-54742https://curecurrent.com/trials/a-study-to-assess-adherence-to-apalutamide-in-metastatic-hormone-sensitive-prostate-cancer-participants-in-france-54743https://curecurrent.com/trials/a-study-of-apalutamide-in-participants-with-high-risk-localized-or-locally-advanced-prostate-cancer-who-are-candidates-f-54744https://curecurrent.com/trials/a-study-of-an-intermittent-adt-approach-with-apalutamide-monotherapy-in-participants-with-mcspc-54745https://curecurrent.com/trials/mr-guided-cryoablation-of-prostate-bed-recurrences-54746https://curecurrent.com/trials/risk-stratified-de-escalated-hormone-therapy-with-radiation-therapy-for-the-treatment-of-prostate-cancer-54747https://curecurrent.com/trials/dec003m-in-prostate-cancer-54748https://curecurrent.com/trials/a-study-of-pasritamig-with-docetaxel-versus-docetaxel-in-participants-with-metastatic-castration-resistant-prostate-canc-54749https://curecurrent.com/trials/a-study-of-androgen-receptor-ar-antagonist-apalutamide-in-chinese-participants-with-metastatic-castration-resistant-pros-54750https://curecurrent.com/trials/an-efficacy-and-safety-study-of-jnj-56021927-apalutamide-in-high-risk-prostate-cancer-subjects-receiving-primary-radiati-54751https://curecurrent.com/trials/a-study-of-jnj-98768111-in-participants-with-advanced-prostate-cancer-54752https://curecurrent.com/trials/screening-for-prostate-cancer-using-high-resolution-micro-ultrasound-versus-multiparametric-magnetic-resonance-imaging-54753https://curecurrent.com/trials/micro-ultrasound-guided-focal-laser-ablation-for-intermediate-risk-prostate-cancer-safety-effectiveness-54754https://curecurrent.com/trials/a-study-to-learn-how-pf-06821497-mevrometostat-works-in-men-with-metastatic-castration-resistant-prostate-cancer-54755https://curecurrent.com/trials/a-study-of-niraparib-in-combination-with-abiraterone-acetate-and-prednisone-versus-abiraterone-acetate-and-prednisone-fo-54756https://curecurrent.com/trials/reduce-heat-a-randomized-trial-of-wearable-thermal-devices-for-adt-induced-hot-flashes-54757https://curecurrent.com/trials/magnetic-resonance-whole-body-diffusion-weighted-imaging-in-finding-bone-or-lymph-node-metastasis-in-participants-with-h-54758https://curecurrent.com/trials/18f-psma-1007-pet-ct-in-prostate-cancer-access-trial-2022-to-2028-54759https://curecurrent.com/trials/a-study-to-learn-how-safe-the-study-treatment-actinium-225-macropa-pelgifatamab-bay3546828-is-how-it-affects-the-body-ho-54760https://curecurrent.com/trials/a-study-in-patients-with-metastatic-castration-resistant-prostate-cancer-54761https://curecurrent.com/trials/a-phase-1-study-of-bpx-601-car-t-cell-therapy-in-adult-participants-with-prostate-cancer-that-has-returned-is-resistant-54762https://curecurrent.com/trials/clinical-trial-to-test-efficacy-of-targeting-hypoxia-combined-with-arsi-after-first-line-arsi-therapy-for-castrate-resis-54763https://curecurrent.com/trials/this-study-will-explore-whether-a-combination-of-the-investigational-drug-mevrometostat-pf-06821497-and-enzalutamide-wil-54764https://curecurrent.com/trials/a-clinical-study-of-hrs-7525-tablets-in-patients-with-advanced-prostate-cancer-54765https://curecurrent.com/trials/testing-interruption-of-hormonal-medications-in-patients-responding-exceptionally-to-therapy-for-metastatic-prostate-can-54766https://curecurrent.com/trials/mr-radiomic-features-in-prostate-cancer-54767https://curecurrent.com/trials/diagnostic-performance-of-acp3-targeted-pet-imaging-in-patients-with-primary-and-recurrent-prostate-cancer-an-open-label-54768https://curecurrent.com/trials/a-study-of-dxc008-in-patients-with-prostate-cancer-and-other-solid-tumors-54769https://curecurrent.com/trials/androgen-deprivation-therapy-relugolix-for-the-improvement-of-diagnostic-imaging-psma-pet-ct-scan-in-patients-with-high-54770https://curecurrent.com/trials/monitoring-treatment-response-with-urine-and-serum-metabolome-markers-in-patients-treated-with-novel-hormone-therapy-and-54771https://curecurrent.com/trials/an-observational-study-to-learn-more-about-the-safety-of-darolutamide-in-men-with-prostate-cancer-in-korea-54772https://curecurrent.com/trials/study-of-dato-dxd-as-monotherapy-and-in-combination-with-anti-cancer-agents-in-patients-with-advanced-solid-tumours-trop-54773https://curecurrent.com/trials/a-study-to-learn-about-how-safe-darolutamide-is-and-how-well-it-works-in-combination-with-androgen-deprivation-therapy-a-54774https://curecurrent.com/trials/nepc-study-an-exploratory-safety-and-efficacy-study-with-psma-sstr2-and-grpr-targeted-radioligand-therapy-in-metastatic-54775https://curecurrent.com/trials/open-label-study-comparing-aaa817-versus-standard-of-care-in-the-treatment-of-previously-treated-psma-positive-mcrpc-adu-54776https://curecurrent.com/trials/psma-high-ebrt-psma617-adt-vs-ebrt-adt-54777https://curecurrent.com/trials/cv-care-cardiovascular-care-in-pc-patients-54778https://curecurrent.com/trials/an-open-label-study-comparing-lutetium-177lu-vipivotide-tetraxetan-versus-observation-in-psma-positive-ompc-54779https://curecurrent.com/trials/agriculture-health-study-54780https://curecurrent.com/trials/protoacoustic-imaging-for-3d-mapping-54781https://curecurrent.com/trials/an-open-label-study-of-lutetium-177lu-vipivotide-tetraxetan-aaa617-in-combination-with-arpi-versus-aaa617-in-psma-positi-54782https://curecurrent.com/trials/study-comparing-aaa817-arpi-versus-standard-of-care-in-adult-participants-with-psma-positive-mcrpc-54783https://curecurrent.com/trials/a-study-of-xaluritamig-plus-abiraterone-versus-investigator-s-choice-in-participants-with-chemotherapy-na-ve-metastatic-54784https://curecurrent.com/trials/a-study-to-investigate-the-safety-and-tolerability-of-oral-inr731-single-agent-or-in-combination-with-androgen-receptor-54785https://curecurrent.com/trials/care-of-the-prostate-cancer-patient-and-prospective-procurement-of-prostate-cancer-tissue-54786https://curecurrent.com/trials/eik1005-002-a-clinical-research-study-evaluating-eik1005-a-werner-helicase-inhibitor-as-monotherapy-and-in-combination-w-54787https://curecurrent.com/trials/prospective-monitoring-of-subjects-with-biochemically-recurrent-prostate-cancer-using-18fdcfpyl-54788https://curecurrent.com/trials/dose-optimization-and-diagnostic-performance-in-prostate-cancer-sparrow-staging-prostate-cancer-with-advanced-rm2-radiot-54789https://curecurrent.com/trials/a-study-of-checkpoint-inhibitors-in-men-with-progressive-metastatic-castrate-resistant-prostate-cancer-characterized-by-54790https://curecurrent.com/trials/androgen-receptor-directed-therapy-on-cognitive-function-in-patients-treated-with-darolutamide-or-enzalutamide-54791https://curecurrent.com/trials/exercise-induced-steroid-changes-in-active-surveillance-for-prostate-cancer-54792https://curecurrent.com/trials/rectal-spacers-use-in-prostate-cancer-radiation-therapy-54793https://curecurrent.com/trials/dyadic-step-sexpcare-for-sexual-health-in-chinese-prostate-cancer-survivors-and-their-female-partners-54794https://curecurrent.com/trials/a-phase-1-study-of-autologous-dendritic-cell-immunotherapy-in-patients-with-mcrpc-54795https://curecurrent.com/trials/psma-pet-guided-de-escalation-of-salvage-radiation-treatment-in-recurrent-prostate-cancer-54796https://curecurrent.com/trials/predictive-and-prognostic-markers-for-treatment-outcomes-in-prostate-cancer-patients-54797https://curecurrent.com/trials/risk-adapted-stereotactic-radiotherapy-vs-standard-of-care-radiotherapy-in-patients-with-prostate-cancer-in-the-adjuvant-54798https://curecurrent.com/trials/evaluation-of-radioligand-treatment-in-men-with-metastatic-castration-resistant-prostate-cancer-with-161tb-tb-psma-i-t-54799https://curecurrent.com/trials/study-of-psma-targeted-therapy-and-androgen-receptor-suppression-in-low-volume-metastatic-prostate-cancer-sparkle-trial-54800https://curecurrent.com/trials/neoadjuvant-dietary-intervention-in-intermediate-risk-prostate-cancer-54801https://curecurrent.com/trials/a-study-of-jsb462-luxdegalutamide-plus-lutetium-177lu-vipivotide-tetraxetan-in-patients-with-metastatic-castration-resis-54802https://curecurrent.com/trials/a-phase-ii-study-evaluating-t-cell-clonality-after-stereotactic-body-radiation-therapy-alone-and-in-combination-with-the-54803https://curecurrent.com/trials/adaptive-versus-non-adaptive-radiotherapy-and-2-bladder-filling-instructions-for-patients-with-intermediate-or-high-risk-54804https://curecurrent.com/trials/multi-modality-imaging-pca-using-sodium-mri-and-psma-pet-in-men-pre-prostatectomy-54805https://curecurrent.com/trials/utilization-of-educational-interventions-in-completion-of-genetic-testing-in-black-patients-with-high-risk-prostate-canc-54806https://curecurrent.com/trials/phase-i-ii-study-of-pegylated-arginine-deiminase-adi-peg20-with-carboplatin-and-cabazitaxel-in-men-with-aggressive-varia-54807https://curecurrent.com/trials/comparing-two-different-boost-approaches-in-radiation-therapy-for-people-with-prostate-cancer-54808https://curecurrent.com/trials/a-phase-i-study-of-jsb462-luxdegalutamide-in-japanese-patients-with-metastatic-prostate-cancer-54809https://curecurrent.com/trials/a-phase-iii-trial-of-bnt324-versus-docetaxel-in-metastatic-castration-resistant-prostate-cancer-54810https://curecurrent.com/trials/an-open-label-study-of-jsb462-luxdegalutamide-in-combination-with-abiraterone-in-adult-male-patients-with-metastatic-hor-54811https://curecurrent.com/trials/an-open-label-dose-escalation-and-expansion-followed-by-a-phase-ii-study-of-tulmimetostat-dzr123-and-jsb462-luxdegalutam-54812https://curecurrent.com/trials/focal-therapy-with-stereotactic-body-radiation-therapy-sbrt-for-patients-with-a-single-prostate-tumor-54813https://curecurrent.com/trials/sbrt-versus-hypofractionated-radiotherapy-for-biochemically-recurrent-or-oligometastatic-prostate-adenocarcinoma-54814https://curecurrent.com/trials/high-dose-testosterone-for-atm-cdk12-or-chek2-altered-prostate-cancers-54815https://curecurrent.com/trials/for46-in-combination-with-enzalutamide-in-patients-with-metastatic-castration-resistant-prostate-cancer-54816https://curecurrent.com/trials/adaptive-abiraterone-therapy-for-metastatic-castration-resistant-prostate-cancer-54817https://curecurrent.com/trials/cosmap-trial-sp-ea-vs-mp-ta-robot-assisted-radical-prostatectomy-54818https://curecurrent.com/trials/a-study-of-hrs-5041-tablets-combined-with-antitumor-therapy-in-subjects-with-advanced-prostate-cancer-54819https://curecurrent.com/trials/phase-1-trial-to-study-janx013-and-janx007-combination-in-mcrpc-54820https://curecurrent.com/trials/spectra-intraoperative-hyperspectral-imaging-for-prostate-cancer-54821https://curecurrent.com/trials/artificial-intelligence-to-personalize-prostate-cancer-treatment-the-hypoelect-trial-54822https://curecurrent.com/trials/standard-moderately-hypofractionated-rt-vs-ultra-hypofractionated-focal-lesion-ablative-microboost-in-prostate-cancer-54823https://curecurrent.com/trials/psma-pet-staged-comprehensive-progression-directed-radiotherapy-for-limited-progression-in-prostate-cancer-54824https://curecurrent.com/trials/a-pilot-study-of-dose-de-escalation-in-prostate-radiotherapy-using-the-mrl-54825https://curecurrent.com/trials/hypo-combi-trial-hypofractionated-ebrt-plus-hdr-bt-boost-for-prostate-cancer-54826https://curecurrent.com/trials/carboplatin-or-olaparib-for-brca-deficient-prostate-cancer-54827https://curecurrent.com/trials/ai-chatbot-for-prostate-radiation-therapy-patient-education-54828https://curecurrent.com/trials/exercise-therapy-and-radiation-therapy-exert-for-metastatic-prostate-cancer-54829https://curecurrent.com/trials/18f-dcfpyl-imaging-as-a-method-to-assess-treatment-response-to-stereotactic-body-radiation-therapy-54830https://curecurrent.com/trials/two-fraction-hdr-monotherapy-for-localized-prostate-cancer-54831https://curecurrent.com/trials/multiparametric-mri-in-men-with-prostate-cancer-undergoing-active-surveillance-54832https://curecurrent.com/trials/real-world-clinical-experience-of-patients-with-metastatic-castration-resistant-prostate-cancer-treated-with-olaparib-ab-54833https://curecurrent.com/trials/cancer-of-the-prostate-treated-with-focal-implantation-of-a-radioactive-source-54834https://curecurrent.com/trials/phase-ii-trial-of-zanzalitinib-in-patients-with-metastatic-castration-resistant-prostate-cancer-54835https://curecurrent.com/trials/multiparametric-mri-in-men-with-prostate-cancer-enrolled-in-active-surveillance-54836https://curecurrent.com/trials/combination-of-nivolumab-immunotherapy-with-radiation-therapy-and-androgen-deprivation-therapy-54837https://curecurrent.com/trials/pilot-study-to-investigate-magnetic-resonance-mr-image-guided-focal-therapy-in-prostate-cancer-54838https://curecurrent.com/trials/cannabidiol-for-pain-relief-of-patients-with-end-stage-mcrpc-54839https://curecurrent.com/trials/first-time-in-human-study-of-gsk5471713-in-adults-with-mcrpc-54840https://curecurrent.com/trials/robotic-vs-laparoscopic-and-open-surgery-for-abdominopelvic-cancers-54841https://curecurrent.com/trials/an-efficacy-and-safety-study-of-enzalutamide-plus-androgen-deprivation-therapy-adt-versus-placebo-plus-adt-in-chinese-pa-54842https://curecurrent.com/trials/study-of-sipuleucel-t-with-or-without-continuing-new-hormonal-agents-in-metastatic-prostate-cancer-54843https://curecurrent.com/trials/implementation-of-a-new-algorithm-for-hrr-gene-mutation-testing-in-patients-with-mpc-through-liquid-biopsy-integration-54844https://curecurrent.com/trials/targeted-and-perilesional-or-systematic-biopsy-in-prostate-cancer-54845https://curecurrent.com/trials/mdrt-in-prostate-cancer-treated-with-long-term-androgen-deprivation-therapy-in-the-stampede-trial-metanova-54846https://curecurrent.com/trials/enzalutamide-and-cabazitaxel-in-treating-patients-with-metastatic-castration-resistant-prostate-cancer-54847https://curecurrent.com/trials/a-study-comparing-single-port-and-multi-port-robot-assisted-surgery-in-patients-with-prostate-or-kidney-renal-cancer-54848https://curecurrent.com/trials/radical-prostatectomy-without-prior-biopsy-54849https://curecurrent.com/trials/developing-inclusive-support-and-intervention-for-spanish-speaking-latin-prostate-cancer-survivors-54850https://curecurrent.com/trials/a-biomarker-study-in-men-with-localized-prostate-cancer-treated-with-aglatimagene-besadenovec-54851https://curecurrent.com/trials/a-study-of-225ac-ac-aky-2519-in-patients-with-metastatic-castration-resistant-prostate-cancer-54852https://curecurrent.com/trials/development-of-a-preclinical-3d-vascularized-and-perfused-tumoroid-model-in-oncology-and-urology-developed-from-patient-54853https://curecurrent.com/trials/trial-of-xaluritamig-in-adults-with-metastatic-castration-resistant-prostate-cancer-54854https://curecurrent.com/trials/development-and-evaluation-of-a-quantitative-hp-mri-for-clinical-prostate-cancer-exam-54855https://curecurrent.com/trials/an-observational-registry-assessing-the-impact-of-pylarify-piflufolastat-f18-pet-in-patients-with-prostate-cancer-54856https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-safety-pharmacokinetics-and-dosimetry-of-177lu-lu-psma-617-in-chinese-adult-male-patien-54857https://curecurrent.com/trials/artificial-intelligence-driven-personalisation-of-radiotherapy-and-concomitant-androgen-deprivation-therapy-for-prostate-54858https://curecurrent.com/trials/promise-registry-a-prostate-cancer-registry-of-outcomes-and-germline-mutations-for-improved-survival-and-treatment-effec-54859https://curecurrent.com/trials/a-study-to-learn-how-well-darolutamide-administered-together-with-androgen-deprivation-therapy-adt-works-in-men-with-met-54860https://curecurrent.com/trials/clinico-biological-database-in-patients-treated-with-metabolic-radiotherapy-in-the-nuclear-medicine-department-54861https://curecurrent.com/trials/multiparametric-mri-in-evaluating-cancer-stage-and-helping-treatment-planning-in-patients-with-prostate-cancer-54862https://curecurrent.com/trials/development-and-validation-of-a-non-invasive-ai-diagnostic-model-for-prostate-cancer-using-multiparametric-mri-and-psma-54863https://curecurrent.com/trials/this-study-evaluates-the-diagnostic-performance-and-safety-of-68ga-nym032-pet-ct-imaging-in-patients-with-suspected-recu-54864https://curecurrent.com/trials/investigation-of-impact-of-ai-on-prostate-cancer-workflow-54865https://curecurrent.com/trials/a-study-of-changes-to-prostate-procedures-54866https://curecurrent.com/trials/effectiveness-of-the-spaceoar-vue-system-in-subjects-with-prostate-cancer-54867https://curecurrent.com/trials/antiandrogen-therapy-and-radiation-therapy-with-or-without-docetaxel-in-treating-patients-with-prostate-cancer-that-has-54868https://curecurrent.com/trials/spaceit-hydrogel-system-for-perirectal-spacing-54869https://curecurrent.com/trials/phase-i-dose-escalation-study-of-fractionated-177lu-psma-617-for-progressive-metastatic-crpc-54870https://curecurrent.com/trials/spatial-multi-omics-of-perineural-invasion-microenvironment-and-prognosis-in-prostate-cancer-54871https://curecurrent.com/trials/predicting-the-risk-of-failure-in-patients-undergoing-radiation-therapy-for-localized-prostate-cancer-54872https://curecurrent.com/trials/the-sugar-study-sbrt-and-relugolix-for-prostate-cancer-54873https://curecurrent.com/trials/abiraterone-acetate-prednisone-and-apalutamide-with-or-without-ipilimumab-or-cabazitaxel-and-carboplatin-in-treating-pat-54874https://curecurrent.com/trials/brachytherapy-for-prostatic-carcinoma-patients-54875https://curecurrent.com/trials/intratumoral-microbiota-and-immune-microenvironment-in-prostate-cancer-54876https://curecurrent.com/trials/sacral-neuromodulation-for-male-overactive-bladder-moab-54877https://curecurrent.com/trials/investigation-of-glp1-receptor-agonists-in-men-with-prostate-cancer-taking-androgen-deprivation-therapy-54878https://curecurrent.com/trials/prostate-specific-membrane-antigen-psma-imaging-for-detection-of-residual-and-metastatic-prostate-cancer-54879https://curecurrent.com/trials/18f-fluoro-2-deoxy-d-glucose-and-18f-dihydro-testosterone-pet-imaging-in-patients-with-progressive-prostate-or-salivary-54880https://curecurrent.com/trials/feasibility-and-effect-of-wrapping-nerves-with-a-multi-layer-perinatal-tissue-allograft-during-prostatectomy-54881https://curecurrent.com/trials/proton-therapy-vs-imrt-for-low-or-intermediate-risk-prostate-cancer-54882https://curecurrent.com/trials/a-phase-ii-study-of-aaa617-alone-and-aaa617-in-combination-with-arpi-in-patients-with-psma-pet-scan-positive-crpc-54883https://curecurrent.com/trials/transperineal-micro-ultrasound-for-the-detection-of-prostate-cancer-during-biopsy-54884https://curecurrent.com/trials/phase-i-ii-study-of-225ac-ac-psma-r2-in-psma-positive-prostate-cancer-with-without-prior-177lu-psma-rlt-54885https://curecurrent.com/trials/a-study-for-subjects-with-prostate-cancer-who-previously-participated-in-an-enzalutamide-clinical-study-54886https://curecurrent.com/trials/prostasomes-as-diagnostic-tool-for-prostate-cancer-detection-54887https://curecurrent.com/trials/positron-emission-tomography-using-64cu-sar-bispsma-in-participants-with-high-risk-prostate-cancer-prior-to-radical-pros-54888https://curecurrent.com/trials/sipuleucel-t-with-or-without-radiation-therapy-in-treating-patients-with-hormone-resistant-metastatic-prostate-cancer-54889https://curecurrent.com/trials/177lu-psma-617-vs-androgen-receptor-directed-therapy-in-the-treatment-of-progressive-metastatic-castrate-resistant-prost-54890https://curecurrent.com/trials/study-of-the-efficacy-safety-and-quality-of-life-after-tookad-soluble-vtp-for-intermediate-risk-prostate-cancer-54891https://curecurrent.com/trials/capivasertib-abiraterone-as-treatment-for-patients-with-metastatic-hormone-sensitive-prostate-cancer-and-pten-deficiency-54892https://curecurrent.com/trials/docetaxel-or-cabazitaxel-with-or-without-darolutamide-in-mcrpc-54893https://curecurrent.com/trials/safety-and-efficacy-of-otl78-zopocianine-54894https://curecurrent.com/trials/immediate-curative-vs-conservative-treatment-in-older-men-with-m0-high-risk-prostate-cancer-54895https://curecurrent.com/trials/psma-pet-ct-guided-sbrt-plus-darolutamide-in-mhspc-54896https://curecurrent.com/trials/debunking-the-frailty-sarcopenia-adt-axis-in-metastatic-prostate-cancer-with-multicomponent-exercise-the-fierce-trial-54897https://curecurrent.com/trials/a-phase-1-2-trial-of-adi-212-in-mcrpc-54898https://curecurrent.com/trials/effect-of-trendelenburg-position-and-pneumoperitoneum-on-optic-nerve-sheath-diameter-in-robot-assisted-prostatectomy-54899https://curecurrent.com/trials/prospective-prostate-cancer-infrastructure-54900https://curecurrent.com/trials/pembrolizumab-plus-177lu-psma-617-in-patients-with-castration-resistant-prostate-cancer-54901https://curecurrent.com/trials/robotic-radical-perineal-prostatectomy-study-54902https://curecurrent.com/trials/prostate-irreversible-electroporation-study-54903https://curecurrent.com/trials/sipuleucel-t-combined-with-bipolar-androgen-therapy-in-men-with-mcrpc-54904https://curecurrent.com/trials/testing-shorter-duration-radiation-therapy-versus-the-usual-radiation-therapy-in-patients-with-high-risk-prostate-cancer-54905https://curecurrent.com/trials/m9466-alone-or-in-combination-in-advanced-solid-tumors-ddriver-501-54906https://curecurrent.com/trials/daily-adaptive-radiation-therapy-using-an-individualized-approach-for-prostate-cancer-54907https://curecurrent.com/trials/the-dosimetry-safety-and-diagnostic-efficacy-of-ga-fc516-in-healthy-subjects-and-patients-with-prostate-cancer-54908https://curecurrent.com/trials/multimodal-prehabilitation-and-rehabilitation-for-men-undergoing-robot-assisted-radical-prostatectomy-54909https://curecurrent.com/trials/first-in-human-study-to-evaluate-azd8359-steap2-tce-in-participants-with-prostate-cancer-54910https://curecurrent.com/trials/advanced-diffusion-magnetic-resonance-prostate-imaging-for-reducing-extraneous-biopsies-aspire-calibration-component-mul-54911https://curecurrent.com/trials/prostate-cancer-enhanced-diagnosis-by-calibration-technology-54912https://curecurrent.com/trials/cabazitaxel-carboplatin-and-cetrelimab-followed-by-niraparib-with-or-without-cetrelimab-for-the-treatment-of-aggressive-54913https://curecurrent.com/trials/pacritinib-in-participants-with-metastatic-castrate-resistant-prostate-cancer-that-progressed-on-or-after-prior-treatmen-54914https://curecurrent.com/trials/akt-inhibitor-mk2206-and-hydroxychloroquine-in-treating-patients-with-advanced-solid-tumors-melanoma-prostate-or-kidney-54915https://curecurrent.com/trials/testing-the-safety-of-different-doses-of-olaparib-given-radium-223-for-men-with-advanced-prostate-cancer-with-bone-metas-54916https://curecurrent.com/trials/genomics-in-michigan-to-adjust-outcomes-in-prostate-cancer-g-major-for-men-with-newly-diagnosed-favorable-risk-prostate-54917https://curecurrent.com/trials/re-irradiation-for-isolated-focal-recurrence-of-prostate-cancer-with-ultrahypofracted-sbrt-54918https://curecurrent.com/trials/study-of-cabozantinib-and-nivolumab-in-metastatic-castration-resistant-prostate-cancer-54919https://curecurrent.com/trials/a-multicenter-open-label-phase-i-clinical-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-efficacy-of-shr-54920https://curecurrent.com/trials/comparing-water-vapour-thermal-therapy-rez-m-and-turp-54921https://curecurrent.com/trials/hemodynamic-monitoring-guided-goal-directed-fluid-therapy-in-robotic-radical-prostatectomy-54922https://curecurrent.com/trials/prostate-specific-membrane-antigen-pet-ct-imaging-in-psma-related-disease-patients-54923https://curecurrent.com/trials/radiotherapy-to-consolidate-systemic-response-in-metastatic-prostate-cancer-anchor-prostate-54924https://curecurrent.com/trials/low-dose-naltrexone-ldn-for-management-of-fatigue-in-prostate-cancer-patients-on-androgen-deprivation-therapy-adt-54925https://curecurrent.com/trials/prostate-specific-membrane-antigen-pmsa-based-pet-imaging-of-high-risk-prostate-cancer-54926https://curecurrent.com/trials/investigating-sx-682-in-combination-with-apalutamide-in-metastatic-castration-resistant-prostate-cancer-54927https://curecurrent.com/trials/profiling-of-radiological-factors-in-treatment-and-outcomes-in-prostate-cancer-54928https://curecurrent.com/trials/longitudinal-advanced-prostate-cancer-cohort-lapcc-54929https://curecurrent.com/trials/radioguided-salvage-pelvic-node-dissection-in-oligometastatic-prostate-cancer-salvage-54930https://curecurrent.com/trials/hpi-effect-in-robotic-urological-surgery-on-aki-54931https://curecurrent.com/trials/study-of-talazoparib-with-enzalutamide-in-men-with-ddr-gene-mutated-mcspc-54932https://curecurrent.com/trials/ai-assisted-patient-support-in-mhspc-54933https://curecurrent.com/trials/il-18-armored-steap1-car-t-cells-for-the-treatment-of-metastatic-castration-resistant-prostate-cancer-54934https://curecurrent.com/trials/to-evaluate-if-green-tea-can-be-effective-in-reducing-the-progression-of-prostate-cancer-in-men-on-close-monitoring-54935https://curecurrent.com/trials/evaluating-hormone-therapy-to-achieve-optimal-doses-in-metastatic-prostate-cancer-54936https://curecurrent.com/trials/the-safety-dosimetry-and-efficacy-of-177lu-fc516-in-patients-with-prostate-cancer-54937https://curecurrent.com/trials/hyperpolarized-hp-13c-pyruvate-magnetic-resonance-imaging-mri-for-response-monitoring-to-neoadjuvant-abiraterone-54938https://curecurrent.com/trials/evaluation-of-xaluritamig-in-high-risk-biochemically-recurrent-non-metastatic-castrate-sensitive-prostate-cancer-54939https://curecurrent.com/trials/comparing-standard-of-care-biopsy-system-to-a-novel-biopsy-needle-system-by-computational-pathologic-analysis-54940https://curecurrent.com/trials/177lu-psma-i-t-for-metastatic-castration-resistant-prostate-cancer-54941https://curecurrent.com/trials/enzalutamide-and-pds01adc-in-pet-positive-recurrent-prostate-cancer-pprpc-without-testosterone-lowering-therapy-54942https://curecurrent.com/trials/radiation-treatment-of-the-prostate-that-is-specially-adjusted-for-each-person-54943https://curecurrent.com/trials/multimodal-therapy-for-the-treatment-of-fatigue-in-patients-with-prostate-cancer-receiving-radiotherapy-with-androgen-de-54944https://curecurrent.com/trials/dose-descalated-mr-guided-radiotherapy-for-localized-prostate-cancer-54945https://curecurrent.com/trials/rehabilitation-and-sex-therapy-to-optimize-recovery-after-prostate-cancer-treatment-54946https://curecurrent.com/trials/study-of-janx014-in-subjects-with-metastatic-castration-resistant-prostate-cancer-54947https://curecurrent.com/trials/short-course-adt-for-high-risk-low-intermediate-risk-artera-prostate-cancer-54948https://curecurrent.com/trials/ab-3028-a-programmable-circuit-t-cell-therapy-in-patients-with-castration-resistant-prostate-cancer-crpc-54949https://curecurrent.com/trials/a-phase-i-ii-study-of-pds01adc-with-docetaxel-and-abiraterone-in-adults-with-metastatic-castration-sensitive-and-pds01ad-54950https://curecurrent.com/trials/feasibility-of-patient-centered-home-care-pchc-to-reduce-disparities-in-high-risk-black-men-bm-with-prostate-cancer-cap-54951https://curecurrent.com/trials/a-phase-2-study-to-evaluate-the-effects-of-asp5541-in-participants-with-prostate-cancer-54952https://curecurrent.com/trials/patient-navigation-program-to-improve-clinical-trial-enrollment-in-cancer-patients-54953https://curecurrent.com/trials/efficacy-and-safety-study-of-qlg1080-in-patients-with-hormone-sensitive-advanced-prostate-cancer-54954https://curecurrent.com/trials/18f-dcfpyl-psma-versus-18f-naf-pet-imaging-for-detection-of-metastatic-prostate-cancer-54955https://curecurrent.com/trials/serial-mri-scans-during-radiation-therapy-54956https://curecurrent.com/trials/survival-outcomes-in-metastatic-prostate-cancer-in-the-brazilian-population-analysis-of-individual-characteristics-and-t-54957https://curecurrent.com/trials/contributions-to-hypertension-with-androgen-deprivation-therapy-54958https://curecurrent.com/trials/18f-dcfpyl-pet-ct-in-high-risk-and-recurrent-prostate-cancer-54959https://curecurrent.com/trials/a-study-to-learn-how-safe-azd6621-is-how-well-it-works-and-how-it-moves-throughout-the-body-over-time-in-adult-male-part-54960https://curecurrent.com/trials/a-study-of-mri-guided-high-dose-radiation-therapy-in-prostate-cancer-54961https://curecurrent.com/trials/efficacy-and-safety-of-pembrolizumab-mk-3475-plus-enzalutamide-plus-androgen-deprivation-therapy-adt-versus-placebo-plus-54962https://curecurrent.com/trials/fluciclovine-f18-or-ga68-psma-pet-ct-to-enhance-prostate-cancer-outcomes-54963https://curecurrent.com/trials/prostate-active-surveillance-study-54964https://curecurrent.com/trials/prostate-cancer-health-education-to-promote-early-sreening-uptake-screen-a-pilot-randomised-control-trial-54965https://curecurrent.com/trials/neoadjuvant-intraprostatic-onabotulinumtoxina-before-radical-prostatectomy-for-high-risk-localized-prostate-cancer-54966https://curecurrent.com/trials/mri-based-machine-learning-approach-versus-radiologist-mri-reading-for-the-detection-of-prostate-cancer-the-primer-trial-54967https://curecurrent.com/trials/external-beam-and-radioligand-radiotherapy-for-mcrpc-54968https://curecurrent.com/trials/local-ablative-radiotherapy-for-oligoprogressive-castration-resistant-prostate-cancer-54969https://curecurrent.com/trials/stereotactic-body-radiation-therapy-in-treating-patients-with-prostate-cancer-after-undergoing-surgery-54970https://curecurrent.com/trials/mri-risk-maps-for-prostate-cancer-diagnosis-using-targeted-biopsy-54971https://curecurrent.com/trials/clinical-evaluation-of-srt-017-in-patients-with-psma-positive-metastatic-castration-resistant-prostate-cancer-54972https://curecurrent.com/trials/preference-based-comparative-study-on-definitive-radiotherapy-of-prostate-cancer-with-protons-54973https://curecurrent.com/trials/study-of-recurrence-directed-therapy-rdt-with-or-without-androgen-deprivation-therapy-adt-in-patients-with-radio-recurre-54974https://curecurrent.com/trials/ipsilateral-versus-bilateral-systematic-biopsy-combined-with-mri-ultrasound-cognitive-fusion-targeted-biopsy-for-prostat-54975https://curecurrent.com/trials/study-of-hrs-5041-in-patients-with-metastatic-castration-resistant-prostate-cancer-mcrpc-54976https://curecurrent.com/trials/a-study-of-tarlatamab-for-people-with-prostate-cancer-54977https://curecurrent.com/trials/the-effect-of-metformin-in-patients-with-newly-diagnosed-mhspc-54978https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-177lu-nym032-injection-in-participants-with-progressive-psma-positive-metas-54979https://curecurrent.com/trials/a-prospective-study-based-on-spatial-multi-omics-to-predict-the-efficacy-of-adt-combined-with-second-generation-novel-ho-54980https://curecurrent.com/trials/a-study-of-enzalutamide-plus-the-glucocorticoid-receptor-antagonist-relacorilant-versus-placebo-for-patients-with-high-r-54981https://curecurrent.com/trials/informed-decision-making-regarding-prostate-specific-antigen-psa-screening-in-50-70-year-old-latino-men-54982https://curecurrent.com/trials/estrogen-to-improve-quality-of-life-for-men-with-newly-diagnosed-or-recurrent-metastatic-hormone-sensitive-prostate-canc-54983https://curecurrent.com/trials/dietary-fibre-supplementation-to-delay-disease-progression-in-early-prostate-cancer-54984https://curecurrent.com/trials/safety-and-efficacy-of-agn-inm176-in-prostate-patients-with-rising-psa-54985https://curecurrent.com/trials/proa-study-proactive-management-model-in-metastatic-hormone-sensitive-prostate-cancer-mhspc-treated-by-apalutamide-54986https://curecurrent.com/trials/registry-for-prostate-cancer-focal-therapy-54987https://curecurrent.com/trials/extreme-bipolar-androgen-therapy-with-darolutamide-and-testosterone-cypionate-in-patients-with-metastatic-castration-res-54988https://curecurrent.com/trials/prostate-cryoablation-combined-with-metronomic-cyclophosphamide-for-metastatic-prostate-cancer-54989https://curecurrent.com/trials/highly-conformal-hypofractionated-focally-dose-escalated-post-prostatectomy-radiotherapy-54990https://curecurrent.com/trials/zanzalintinib-in-men-with-aggressive-variant-prostate-cancer-54991https://curecurrent.com/trials/implementation-of-a-telesurgery-program-at-a-referral-center-for-robotic-surgery-54992https://curecurrent.com/trials/focal-micro-boost-strategy-in-patients-with-intermediate-to-high-risk-prostate-cancer-ir-hr-pca-undergoing-hypofractiona-54993https://curecurrent.com/trials/hybrid-intelligence-for-trustable-diagnosis-and-patient-management-of-prostate-cancer-hit-pirads-54994https://curecurrent.com/trials/comparison-of-177lu-psma-617-and-225ac-psma-617-54995https://curecurrent.com/trials/study-on-olaparib-plus-abiraterone-as-first-line-therapy-in-men-with-metastatic-castration-resistant-prostate-cancer-chi-54996https://curecurrent.com/trials/testing-the-effects-of-exercise-on-colorectal-cancer-development-after-treatment-with-pelvic-radiation-therapy-for-prost-54997https://curecurrent.com/trials/prism-study-prostate-recurrence-detection-using-imaging-with-psma-pet-mri-post-high-intensity-focused-ultrasound-54998https://curecurrent.com/trials/ufpti-2403-pr12-real-time-volumetric-ionizing-radiation-acoustic-imaging-for-in-vivo-proton-treatment-monitoring-in-penc-54999https://curecurrent.com/trials/influence-of-electronic-patient-reported-outcomes-eproms-in-surgical-therapy-for-prostate-cancer-on-postoperative-outcom-55000